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INVESTIGATION OF ISCHEMIA-REPERFUSION EFFECTS ON ATF3 
AND GADD45G GENE EXPRESSION IN RAT KIDNEY TISSUES USING 
RT-PCR AND REAL-TIME PCR 
SUMMARY 
Ischemia is a state of tissue oxygen deprivation because of inadequate blood supply 
owing to constriction of the blood vessels or to obstruction. Reperfusion is the 
restoration of blood flow to the ischemic tissue. Whereas ischemic injury is mainly 
due to oxygen-deprived cellular necrosis, reperfusion is highly responsible from the 
injury because it produces an inflammatory response that both heightens local 
damage and leads to systemic insult. Thus, ischemia-reperfusion injury (IRI) causes 
damage in several organs. Pathophysiology of the IRI is complex and inflammatory 
mechanisms play a major role. 
Ischemic preconditioning (IP) and heat preconditioning (HP) are two methods of 
minimizing IRI that can be applied to an organ before an ischemia-reperfusion 
condition to make the organ tolerant to IRI. Activating transcription factor 3 (Atf3) 
and growth arrest- and DNA damage-inducible gamma (Gadd45g) are two genes 
that have been shown to be induced by several stress conditions such as ischemia-
reperfusion. In a previous study with microarray analysis, it was observed that Atf3 
and Gadd45g genes were upregulated when rat kidney tissues were studied for gene 
expression upon ischemia-reperfusion, ischemia-reperfusion with heat 
preconditioning and with ischemic preconditioning. In this study, expression levels 
of these genes upon the same conditions were investigated in total RNA samples 
from rat kidney tissues by using RT-PCR and Real-Time RT-PCR techniques.  
In both techniques, reaction mixtures were prepared as multiplex samples by using 
the internal control gene (-Actin) primers in the same reaction tube. In RT-PCR 
experiments, the annealing condition of 560C for 30 s and 32 cycles of PCR 
amplification were determined as optimum conditions for the multiplex reactions of 
both the Atf3 and Gadd45g genes. cDNA products of the multiplex RT-PCR were 
loaded to agarose gel, and relative quantification of gene expression was done using 
the band volumes obtained by the BioCapt software. In multiplex Real-Time PCR 
experiments, CT values of the obtained cDNAs were determined, and relative 
quantification of gene expression was done by using the 2-Ct method. Relative 
quantification of the treated samples were determined according to Sham control 
samples. 
The resulting values of both techniques were compared with the previously obtained 
microarray results. Results obtained have shown significant expression changes 
under different conditions and were compatible with the microarray data. For both 
Atf3 and Gadd45g genes, the highest increase in gene expression level was observed 
in the IP-conditioned samples and especially in the sample with 60 min reperfusion 
time. For these samples, Atf3 showed higher expression values than Gadd45g. 
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SKEM-REPERFÜZYONUN ATF3 VE GADD45G GEN 
EKSPRESYONLARI ÜZERNDEK ETKLERNN RT-PCR VE REAL-
TIME PCR TEKNKLER KULLANILARAK SIÇAN BÖBREK 
DOKULARINDA NCELENMES 
ÖZET 
skemi, kan damarlarının büzülmesine ya da tıkanmasına balı yetersiz kan akıından 
kaynaklanan doku oksijen yoksunluu durumudur. Reperfüzyon, kan akıının 
iskemik dokuya yeniden gelmesidir. skemik hasar, oksijenden yoksun kalan 
hücrelerin nekrozundan kaynaklanırken hasardan yüksek oranda reperfüzyon 
sorumludur, çünkü reperfüzyonun yol açtıı enflamatuar cevap hem bölgesel hasarı 
artırır hem de sistemik kötülemeye neden olur. Böylece, iskemi-reperfüzyon hasarı 
(IRI) birçok organa zarar verir. IRI’nin patofizyolojisi karmaıktır ve enflamatuar 
mekanizmalar büyük bir rol oynar. 
skemik önkoullama (IP) ve ısı önkoullaması (HP) IRI’yi azaltmanın iki 
yöntemidir ve bir organı IRI’ye dayanıklı hale getirmek için iskemi-reperfüzyon 
durumundan önce uygulanabilir. Aktive edici transkripsiyon faktörü 3 (Atf3) ile 
büyümenin tutuklanması ve DNA hasarı ile indüklenen gama (Gadd45g), iskemi-
reperfüzyon gibi çeitli stres koulları tarafından indüklendii gösterilmi olan iki 
gendir. Daha önce yapılmı olan bir mikroarray analiz çalımasında, sıçan böbrek 
dokularında, iskemi-reperfüzyon, ısı önkoullamasını takiben iskemi-reperfüzyon ve 
iskemik önkoullamayı takiben iskemi-reperfüzyon koullarında gen ekspresyonu 
çalııldıında Atf3 ve Gadd45g genlerinin anlatımının arttıı gözlenmitir. Bu 
çalımada, bu genlerin aynı koullar altındaki anlatım seviyeleri, sıçan böbrek 
dokularından elde edilmi olan total RNA örnekleri üzerinde RT-PCR ve Real-Time 
RT-PCR teknikleri kullanılarak çalıılmıtır. 
Her iki teknikte de, reaksiyon karıımları, aynı reaksiyon tüpünde internal kontrol 
genin (-Aktin) primerleri kullanılarak multipleks örnekler olarak hazırlandı. RT-
PCR çalımalarında, 560C’de 30 saniye primer balanma koulu ve 32 döngülük 
PCR amplifikasyonu, hem Atf3 hem de Gadd45g’nin multipleks reaksiyonları için en 
uygun koullar olarak belirlendi. Multiplex RT-PCR’ın cDNA ürünleri agaroz jele 
yüklendi ve rölatif gen ekspresyonu miktarı, BioCapt yazılımı ile elde edilen bant 
hacimleri kullanılarak hesaplandı. Multiplex Real-Time PCR çalımalarında, elde 
edilen cDNA’ların CT deerleri belirlendi ve 2-Ct yöntemi kullanılarak rölatif gen 
ekspresyonu miktarı hesaplandı. Farklı koullar uygulanan örneklerin rölatif gen 
ekspresyonu miktar tayini, Sham kontrol örneklerine göre belirlendi. 
Her iki tekniin sonuçları, daha önce elde edilmi olan mikroarray sonuçlarıyla 
karılatırılmıtır. Elde edilen sonuçlar, mikroarray verileriyle uyumlu ekilde, farklı 
koullar altında anlamlı ekspresyon deiimleri olduunu göstermitir. Hem Atf3 
hem de Gadd45g genleri için en fazla gen ekspresyonu artıı IP uygulanan 
örneklerde, özellikle de 60 dakikalık reperfüzyon örneinde görülmütür. Bu 
örnekler için Atf3, Gadd45g’den daha yüksek ekspresyon deerleri göstermitir.  
1 
 
1. INTRODUCTION 
1.1 Ischemia-Reperfusion Injury (IRI) 
Ischemia is a state of tissue oxygen deprivation resulting from inadequate blood 
flow. Reperfusion is the restoration of blood flow to the ischemic tissue. Introduction 
of molecular oxygen into cells upon reperfusion elicits a cascade of adverse reactions 
that injure tissue [1, 2]. 
Ischemia-reperfusion injury (IRI) causes organ damage in the brain, heart, lungs, 
liver, kidneys and skeletal muscle [1]. Conditions that trigger IRI include the 
different forms of acute vascular occlusions (stroke, myocardial infarction, limb 
ischemia) with the respective reperfusion strategies (thrombolytic therapy, 
angioplasty, and operative revascularization), also routine surgical procedures (organ 
transplantation, free-tissue-transfer, cardiopulmonary bypass, vascular surgery) and 
major trauma/shock [3]. 
In kidney transplantation, IRI occurs in situations such as graft harvesting, cold 
storage and surgery. Clinical consequences of IRI have been considered to be 
delayed graft function and acute rejection in the short term and chronic rejection late 
after transplantation [4]. 
1.1.1 Pathophysiology of IRI 
The pathophysiology of the IRI is complex (Table 1.1) and inflammatory 
mechanisms play a major role (Figure 1.1). The pathogenetic events mainly involve 
injured endothelium and activated leukocytes and interaction of the two. 
The initial metabolic change during tissue ischemia is energy depletion as a result of 
defective resynthesis of adenosinetriphosphate (ATP) and degradation of it finally to 
hypoxanthine. Under physiological conditions, hypoxanthine is converted to 
xanthine by the enzyme xanthine dehydrogenase. However, under ischemic 
conditions, xanthine dehydrogenase is converted by Ca2+ dependent proteases to 
xanthine oxidase that is capable of generating reactive oxygen species (ROS) [3, 5].
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Table 1.1 : Effects of ischemia-reperfusion injury [3]. 
 
In IRI, homeostasis of oxygen metabolism is altered and highly reactive oxygen 
species such as H2O2, OH- and O2-  accumulate. Upon ischemia, antioxidant defenses 
are depleted and therefore highly destructive hydroxyl radical (OH-) elevates causing 
direct damage to cellular membranes as well as proteins and inducing lipid 
peroxidation. Following restoration of oxygen supply with reperfusion, the 
production of ROS is increased intensely by dysfunctional mitochondria, xanthine 
oxidase and NO synthase (NOS) systems. In addition to cellular lipids and proteins, 
ROS react directly with DNA, leading to cell injury and cell death [2, 3]. 
Depletion of the ATP stores inhibits the active ion transport systems (the sodium 
[Na+]-potassium [Ka+]-ATPase) of ischemic cells. This results in intracellular 
accumulation of sodium and calcium (Ca2+) ions [6, 4]. Consequently, cellular influx 
of water and swelling occur. Intracellular calcium increase exerts detrimental effects 
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by activating the intracellular enzymes proteases and endonucleases which are 
important in proapoptotic signaling, and it activates plasma-membrane phospholipase 
A2 which is an enzyme that activates the arachidonic acid cascade. This cascade 
leads to the production of leukotrienes, which are potent chemotactic agents 
important for the interaction between leukocytes and endothelial cells [3, 4]. 
                                      
Figure 1.1 : Proposed inflammatory cascade in ischemia-reperfusion injury [1]. 
The influx of sodium and calcium induces a consecutive flow of water from the 
vessels into the cells. Swelling of endothelial cells reduces the vascular lumen and 
leads to an obstruction of the capillary flow. Consequently, the local hemodynamic is 
disturbed, platelets begin to aggregate and leukocytes come in a physically closer 
distance to endothelial cells [7]. In addition, following reperfusion, NO which has 
vasodilation properties is decreased whereas endothelin-1, the most powerful 
vasoconstrictor, is dramatically increased. Additionally, disruption of the endothelial 
barrier due to disorganization of junctional adhesion proteins leads to increased fluid 
filtration at the capillary level and macromolecular leakage. All these events lead to 
reduction of capillary perfusion despite adequate restoration of blood flow, and 
constitute the ‘‘no-reflow’’ phenomenon, although early reports have attributed it to 
blockage of capillaries by neutrophils preventing reperfusion [3, 8].  
The degree of tissue damage strongly correlates with the number of recruited 
leukocytes. Various pro-inflammatory factors such as leukotriene B4 and the 
complement activation product C5a activate circulating neutrophils. The process of 
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leukocyte adhesion is initiated by polymorphonuclear leukocytes (PMN) which are 
attracted to the vascular intima and stimulate activities of other leukocyte populations 
[4]. To emigrate into inflamed tissue, leukocytes initially tether to and roll on the 
vascular endothelium (Figure 1.2). This relatively loose adhesion is mediated by the 
P- and E-selectins on the endothelium and L-selectin on leukocytes, while the 
integrin molecules CD11/CD18 on leukocytes and their receptors ICAM-1 and 
ICAM-2 on the endothelium are responsible for sticking and firmer adhesion. 
Leukocyte transmigration is the final stage and occurs between endothelial cells. 
Leukocytes then travel through the extracellular matrix to the site of tissue injury that 
is guided by a concentration gradient of cytokines and chemokines produced at the 
site of injury [1, 4]. 
Figure 1.2 : Current model of leukocyte migration to inflamed tissue [1]. 
In conclusion, ischemia-reperfusion initiates a complex interplay between the 
endothelium, different types of blood cells and leukocytes, leading to microvascular 
injury and cell necrosis or apoptosis. 
1.2 Preconditioning Before IRI 
While ischemic injury is mainly due to oxygen-deprived cellular necrosis, 
reperfusion produces an inflammatory response that both heightens local damage and 
leads to systemic insult. Various methods of limiting reperfusion injury have been 
described such as oxygen radical scavenging, leucodepletion, induced hypothermia 
and controlled reperfusion [9]. 
1.2.1 Ischemic preconditioning (IP) 
In 1986, Murry and colleagues described the phenomenon of ischemic 
preconditioning (IP) which proved to be one of the most powerful methods of 
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minimising ischemia-reperfusion injury (IRI) [9]. Murry et al. demonstrated in the 
canine heart that four cumulative 5 min ischemia-5 min reperfusion periods 
conferred protection from a subsequent 40 min sustained ischaemic insult and 
myocardial infarct size was reduced to 25% of that seen in the control group. On the 
other hand, when an identical preconditioning protocol was followed on the animals 
which then received a sustained 3 hours occlusion, there was no difference between 
infarct size in the preconditioned and control groups. (Note that all animals were 
allowed 4 days of reperfusion after sustained ischemia). The protective effect of 
preconditioning in the 40 min study may have been due to reduced ATP depletion 
and/or to reduced catabolite accumulation during the sustained ischaemic occlusion. 
As a result of the study, the multiple anginal episodes that often precede myocardial 
infarction in man may delay cell death after coronary occlusion, and thereby allow 
for greater salvage of myocardium through reperfusion therapy [10].  
IP is effective within minutes, suggesting that preformed mediators are responsible 
for its effects. Locally released agonists such as adenosine, bradykinin, 
catecholamines and opioids trigger the protective response through various cell 
surface G-protein coupled receptors. Kinases such as protein kinase C, tyrosine 
kinase and p38MAPKinase participate in the signalling pathway. The mitochondrial 
ATP-sensitive potassium (KATP) channels may serve as the end-effector of 
preconditioning [9]. 
 
Figure 1.3 : Biphasic protection induced by a single preconditioning episode [9]. 
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IP induces a biphasic protection from IRI: an initial strong protective stimulus that is 
brief and a later, less powerful but longer lasting protection (Figure 1.3). Repeated 
preconditioning episodes are neither additive nor cumulative (Figure 1.4) [9]. 
 
Figure 1.4 : Multiple preconditioning episodes convert biphasic protection into a 
monophasic pattern. Note that the magnitude of protection is not 
increased and the duration of protection is dictated by the last 
preconditioning stimulus [9]. 
According to a comprehensive review by Pasupathy and Homer-Vanniasinkam 
(2005), IP utilises endogenous mechanisms in skeletal muscle, liver, lung, kidney, 
intestine and brain in animal models to convey varying degrees of protection from 
IRI [9]. Recent reports also suggest that human heart, liver, lung and skeletal muscle 
acquire similar protection after IP. Preconditioned tissues exhibit reduced energy 
requirements (conservation of energy substrates), diminished metabolism, better 
electrolyte homeostasis and genetic reorganisation, giving rise to the concept of 
‘ischemia tolerance’. IP also induces ‘reperfusion tolerance’ with less reactive 
oxygen species and activated neutrophils released, reduced cytokine production and 
apoptosis, and enhanced microcirculatory perfusion compared to nonpreconditioned 
tissue. Systemic IRI is also diminished by preconditioning. IP is ubiquitous but more 
research is required to fully translate these findings to the clinical arena [9]. 
In a study, rats were randomized to sham operation, 45 min renal ischemia, ischemic 
preconditioning with four cycles of 8 min renal ischemia and 5 min reperfusion 
followed by 45 min renal ischemia and systemic adenosine pretreatment before 45 
min renal ischemia. 45 min of renal ischemia followed by 24 hours of reperfusion 
resulted in marked rises in blood urea nitrogen and creatinine. Ischemic 
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preconditioning and adenosine pretreatment protected renal function and improved 
renal morphology. It was demonstrated for the first time that rat kidneys can be 
preconditioned to attenuate IRI, and adenosine infusion before ischemic insult 
protects renal function via A1 adenosine receptor activation [11]. 
In another study, it was found in rats that 15 min of warm ischemia and 10 min of 
reperfusion in the kidney is the most suitable one-cycle schedule for preconditioning 
since it protects from both warm and cold ischemia. Prolongation of the reperfusion 
window (20 or 40 min) abolished the preconditioning protection. The beneficial 
effect of preconditioning is related to the local production of NO, and IP has 
promising therapeutic value in clinical renal transplantation [12].  
1.2.2 Heat preconditioning (HP) 
The heat-shock response consists of the expression of a family of highly conserved 
proteins that are known as heat-shock proteins (HSPs) [13, 14, 15] and for their 
cytoprotective function in a variety of injury models [16]. Recent experimental 
studies have elucidated that the induction of HSPs is capable of reducing ischemic 
necrosis in myocardial, neuronal, and renal tissue [17]. The protective role of heat 
preconditioning (HP) or HSPs is thought to be due to their ability to facilitate 
refolding, assembly, and stabilization of denatured proteins. However, precise 
molecular mechanisms are not well known. The protective effect of HSP-70 is 
partially mediated through inhibition of NF-B pathway–related inflammation, as 
well as modulation of cell necrosis or apoptosis. HP stabilizes IB proteins and 
suppresses their activation in liver IRI or myocardial inflammation. In addition, HSP-
70 has been demonstrated to be protective in renal tubular cell apoptosis [16]. 
Jo et al (2006) have investigated the in vivo effect of HP on inflammation and tubular 
cell necrosis and apoptosis in ischemic ARF in rats. They found that HP attenuated 
the renal injury, and it was accompanied by inhibition of NF-B activation with 
subsequent decrease in inflammation and also decrease in tubular cell necrosis and 
apoptosis. HSP-70 is thought to be responsible for this beneficial effect [16]. 
Another study in rats showed that HP induces renal HSP72 and, for the first time, 
HSP32. HP increases survival following transplantation after 40 hours cold ischemia 
(cold storage) and acts by improving several parameters of kidney function including 
proteinuria, volume output and creatinine clearance [18]. 
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According to a recent study on mice, local heat preconditioning of myocutaneous 
tissue markedly increases flap survival by maintaining adequate nutritive perfusion 
rather than inducing ischemic tolerance. The protection is caused by the increased 
arteriolar blood flow due to significant arteriolar dilation, which is mediated through 
the carbon monoxide-associated vasoactive properties of HSP-32 [17]. 
1.3 ATF3 Gene, its Products and Role in Stress  
1.3.1 ATF3 gene and its products 
Activating transcription factor 3 (ATF3) is a member of the mammalian activating 
transcription factor/cAMP responsive element binding protein (ATF/CREB) family 
of basic leucine zipper (bZip)-type transcription factors [19, 20]. Human ATF3 gene 
is localized on the q32.3 region of the chromosome 1 [21]. ATF3 protein is 
composed of 181 amino acids, and the basic region and leucine zipper domain from 
88 to 147 amino acids are required for dimer formation and specific DNA binding 
[19, 20].  
The homodimer of ATF3 represses transcription from various promoters with ATF 
sites, probably by stabilizing inhibitory co-factors at the promoter, whereas 
heterodimers with c-Jun or JunB activate transcription [19, 20]. In addition to the 
heteromeric forms, various spliced isoforms of ATF3 may further generate functional 
diversity in different cellular context [20]. The splice variant ATF3Zip was isolated 
in serum-stimulated HeLa cells. It lacks the leucine zipper domain and does not bind 
to DNA. It stimulates transcription, presumably by sequestering inhibitory co-factors 
away from the promoter [19]. ATF3Zip2a and -b were isolated from cells treated 
with various stimuli such as A23187, TNF-, endoplasmic reticulum stress, or 
oxidative stress. These two isoforms encode the C-terminally truncated protein of 
135 amino acids. ATF3Zip2 lacks the leucine zipper domain and thus is incapable 
of DNA binding [22]. It sensitizes cells to apoptotic cell death, partially through 
suppressing nuclear factor (NF)-B-dependent transcription of antiapoptotic genes 
such as cIAP2 and XIAP [20]. ATF3Zip2c and ATF3Zip3 were identified in 
amino acid- and glucose-deprived cells [23]. Another isoform, ATF3b, is implicated 
in mediating cAMP signaling of proglucagon transcription in pancreatic -cells [24].  
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1.3.2 Induction of Atf3 expression by extracellular signals 
It has been hypothesized that ATF3 is an immediate-early gene that responds to 
extracellular signals. The evidences are that first, the mRNA level of ATF3 is 
relatively low in most cell types examined, but greatly increases upon serum 
induction or during liver regeneration. Second, the 3’ untranslated region of ATF3 
mRNA contains several AUUUA sequences, a characteristic of the mRNAs of many 
immediate-early genes. Third, ATF3 is similar to c-Fos (a well characterized 
immediate-early gene) in the bZip region [25]. 
When the expression of ATF3 was examined by in situ hybridization in different 
tissues after a variety of treatments, the following correlation was noticed: Signals 
that induce tissue injury increase the levels of ATF3 mRNA, but signals do not 
induce tissue injury fail to do so. Considering the ischemia-reperfusion injury-related 
results, it was found that myocardial ischemia and myocardial ischemia coupled with 
reperfusion induce ATF3 in the heart, and renal ischemia-reperfusion injury induces 
ATF3 in the kidney (Table 1.2). It can be hypothesized from all results that induction 
of ATF3 is a part of the cellular stress responses [25]. 
Table 1.2 : Examples of treatments that induce the expression of ATF3 in tissues of 
whole organisms [25]. 
 
ATF3 has also been demonstrated to be induced in cultured macrophage cells by 
treatment with cytokines such as interferons (IFNs) and interleukin-4 (IL-4), in 
various cell types by genotoxic agents such as ionizing radiation, methyl 
methanesulfonate and ultraviolet (UV) light, and by agents known to induce cell 
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death or the JNK/SAPK signaling pathway such as doxrubicin, Fas antibody, 
anisomycin and cyclohexamide [25]. 
1.3.3 Signaling pathways involved in the induction of Atf3 by extracellular 
signals 
JNK/SAPK pathway plays a role in the induction of ATF3 by stress signals [25]. 
Also, IL-6 and p53 are involved in the induction of ATF3 by extracellular signals. In 
IL-6 deficient mice, the induction is attenuated, but can be rescued by IL-6 injection 
[26]. The induction of ATF3 by genotoxic agents is p53-dependent in some cells 
[27].  
1.3.4 Atf3 in cellular stress responses 
Induction of ATF3 is a part of the cellular stress responses. However, it is not clear 
whether it is a beneficial stress response (such as heat shock response) or a 
detrimental stress response (such as inflammatory response). ATF3 may play a role 
in regulating cell cycle machinery [25]. 
1.4 GADD45G Gene, its Product and Role in Stress 
1.4.1 GADD45G gene and its product 
Myeloid differentiation (MyD) primary response and growth arrest- and DNA 
damage-inducible (Gadd) genes comprise a set of overlapping genes, including 
known (IRF-1, EGR-1, Jun) and novel (MyD88, Gadd45, MyD118/Gadd45, 
CR6/Gadd45, MyD116/Gadd34) genes which are coordinately induced upon the 
onset of terminal myeloid differentiation and exposure of cells to stress stimuli. 
MyD/Gadd genes play a role in blood cell development, and are also involved in 
inflammatory responses to invading micro-organisms, and response to environmental 
stress and physiological stress, such as hypoxia, which results in ischemic tissue 
damage [28, 29]. 
The Gadd45 gene family (Gadd45a, Gadd45b, Gadd45g) encodes for small (18 
kDa), evolutionary conserved proteins that are highly homologous to each other (55-
57% overall identity at the amino acid level), are highly acidic (pI = 4.0-4.2), and are 
primarily localized within the cell nucleus. These are a family of growth suppressive 
and apoptotic proteins which serve similar but not identical functions and interact 
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with cell cycle proteins [28, 29] and play a role in the G2/M checkpoint in response 
to DNA damage [30]. 
CR6 (cytokine response gene 6) gene is the third member of the Gadd45 gene family 
[31] and currently called as Gadd45g (Gadd45, Gadd45gamma) [21]. It was 
originally identified as an immediate early response gene in T cells stimulated by 
interleukin-2 [32]. The full-length sequences of murine and human Gadd45g cDNAs 
were determined [31, 33]. The human Gadd45g gene is localized on the q22.1-q22.2 
region of the chromosome 9 [21]. It encodes a 159 amino acid length protein, which 
is named growth arrest- and DNA damage-inducible protein, gamma [34]. 
1.4.2 Induction of Gadd45g by extracellular signals 
Gadd45 family members are rapidly induced by genotoxic stress agents, as well as 
by terminal differentiation and apoptotic cytokines [35]. 
1.4.3 Gadd45g in stress signaling 
Gadd45 genes have been implicated in stress signaling in response to physiological 
or environmental stressors, which results in cell cycle arrest, DNA repair, cell 
survival and senescence, or apoptosis. Functioning as stress sensors, Gadd45 proteins 
physically interact with other cellular proteins which are implicated in cell cycle 
regulation and the response of cells to stress. These include PCNA, p21, 
cdc2/cyclinB1, and the p38 and JNK stress response kinases. It remains to be 
determined what deterministic factors dictate whether Gadd45 and partner proteins 
function in either cell survival or apoptosis (Figure 1.5) [35]. 
Evidence was obtained that Gadd45b and Gadd45g activate p38/JNK signaling by 
interacting with MEKK4, and cytokine production in effector T cells. MEKK4 is an 
upstream activator of the stress induced p38/JNK kinases, and the stress-responsive 
p38 and JNK MAPK pathways regulate cell cycle and apoptosis [33, 35]. 
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Figure 1.5 : Gadd45g in stress signaling : Coordination of cellular stress responses   
via interaction with partner proteins [35]. 
1.4.4 Gadd45g in cellular stress responses 
Gadd45g was shown to have a role in cell cycle arrest by blocking G1/S and G2/M 
transitions. It mediates G2/M cell cycle arrest due to interacting with and inhibiting 
the kinase activity of the cdc2/cyclinB1 complex. Its interaction with p21 may play a 
role in G1 cell cycle arrest [35].  
Gadd45g has a pro-apoptotic function, and was shown to have a role in neuronal cell 
death. However, interaction of Gadd45g protein with PCNA may promote cell 
survival by enhancing DNA repair [35]. 
1.5 Multiplex Polymerase Chain Reaction (PCR) 
Multiplex polymerase chain reaction (PCR) is a variant of PCR in which two or more 
target sequences can be amplified by including more than one pair of primers in the 
same reaction. Multiplex PCR considerably saves time and effort in the laboratory. 
Since it was first described in 1988, this method has been successfully applied in 
many areas of DNA testing, including gene deletion analysis, mutation and 
polymorphism analysis, quantitative analysis, and reverse-transcription (RT)-PCR. 
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An efficient multiplex PCR usually requires strategic planning and optimization of 
reaction conditions. For a successful multiplex PCR assay, adjusting of primer 
concentration for each target sequence, concentration of the PCR buffer, balance 
between the magnesium chloride and deoxynucleotide concentrations, cycling 
temperatures, and amount of template DNA and Taq DNA polymerase are important 
[36, 37]. 
1.6 Quantitative Reverse Transcription PCR (QRT-PCR) 
Reverse transcription PCR (RT-PCR) represents a sensitive and powerful tool for 
analyzing RNA. It has tremendous potential for quantitative applications, however, a 
comprehensive knowledge of its technical aspects is required. This technique is 
highly sensitive that it permits analysis of gene expression from very small amounts 
of RNA (even at the level of the content of a single cell). Moreover, this method can 
be applied on a large number of samples and/or many different genes in the same 
experiment. This method provides quantification of specific RNA transcripts and the 
detection of any variation in their expression levels under different experimental 
conditions [38, 39]. Figure 1.6 presents the steps in a qRT-PCR approach. 
In this thesis work, an RNA standard as described in Figure 1.6 was not used. The 
RNA standard shown in Figure 1.6 is a homologous, external RNA standard. In this 
thesis work, an internal (endogenous) standard RNA (-Actin) was co-amplified with 
the target RNA in the same tube to be used for relative quantification. 
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Figure 1.6 : Flowchart of the technical steps in qRT-PCR [38]. 
1.7 Quantitative Real-Time Reverse Transcription PCR (QReal-Time RT-PCR) 
The real-time PCR is the technique that uses fluorescent reporter molecules to 
monitor the production of amplification products during each cycle of the PCR 
reaction, thus combines nucleic acid amplification and detection steps into a single 
step. The time (or PCR cycle) where the target amplification is first detected is 
usually referred to as cycle threshold (CT) at which fluorescence intensity is greater 
than background fluorescence. The greater the quantity of target DNA in the starting 
material, the faster a significant increase in fluorescent signal will appear, yielding a 
lower CT [40, 41]. 
There are many benefits of using real-time PCR method over other methods to 
quantify gene expression [40, 41]: 
• Quantitative data can be produced with 7 to 8 log orders of magnitude. 
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• Gel electrophoresis to detect amplification products is not required. 
• Real-time PCR assays are 10,000- to 100,000-fold more sensitive than RNase 
protection assays, 1000-fold more sensitive than dot blot hybridization, and can even 
detect a single copy of a specific transcript.  
• Real-Time PCR can reliably detect gene expression differences as small as 23% 
between samples and have lower coefficients of variation (cv; SYBR Green at 
14.2%; TaqManat 24%) than end point assays such as band densitometry (44.9%) 
and probe hybridization (45.1%).  
• Real-time PCR can also discriminate between messenger RNAs (mRNAs) with 
almost identical sequences, and requires much less RNA template than other 
methods of gene expression analysis. 
The major disadvantage of real-time PCR is that it requires expensive equipment and 
reagents. In addition, a powerful experimental design and a deep understanding of 
normalization techniques are necessary for accurate conclusions [40]. 
Real-time PCR can be performed as either a one-step reaction, where the entire 
reaction from cDNA synthesis to PCR amplification is performed in a single tube, or 
as a two-step reaction, where reverse transcription and PCR amplification occur in 
separate tubes [40]. Figure 1.7 shows the general steps in a real-time PCR 
experiment, from RNA isolation to data analysis. 
There are two methods of quantification of real-time PCR data: absolute 
quantification and relative quantification. Absolute quantification uses a standard 
curve that is generated by serially diluted DNA or RNA standards (such as 1:10 
diluted, 1:100 diluted and so on) of known concentrations. The standard curve 
produces a linear relationship between C and initial amounts of standard sample, 
thus allows the determination of the concentration of unknowns based on their C
values. This method assumes all standards and samples have approximately equal 
amplification efficiencies. In addition, the concentration of serial dilutions should 
comprise the levels in the experimental samples, therefore a more concentrated RNA 
or cDNA sample than the unknown samples should be used to generate a standard 
curve [40]. 
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Figure 1.7 : Steps performed during quantitative real-time PCR [40]. 
1.7.1 Relative quantification 
Relative quantitation of gene expression allows quantifying differences in the 
expression level of a specific target gene between different samples. The data output 
is expressed as a fold-change or a fold-difference of expression levels. For example, 
one can look at the change in expression of a particular gene over a given time period 
in treated vs. untreated samples. For this, a calibrator sample (i.e. untreated at day 0) 
and an endogenous control gene (i.e. Beta-Actin) to normalize input amounts are 
chosen. For all samples, at first, both target and endogenous control gene levels are 
assessed by real-time PCR. Secondly, target level is normalized by endogenous 
control level for all samples. Finally, the normalized results are then expressed in a 
format such as “At day 30, sample A had a 10-fold greater expression level of the 
target gene than at day 0” [42]. 
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Endogenous control is a gene sequence contained in a sample that is used to 
normalize target quantities. In addition to the target sequence, an endogenous control 
is quantified as a means of correcting results that can be skewed by input nucleic acid 
loading differences. Endogenous control has its own set of primers and probe in the 
reaction tube. Endogenous control genes are thought to have stable expression such 
as housekeeping genes like GAPDH (glyceraldehyde-3-phosphate dehydrogenase), 
ACTB (Beta-Actin) and rRNAs. These genes are present in all nucleated cell types, 
and mRNA synthesis of these genes is considered to be stable in various tissues, even 
under experimental treatments. However, these genes have been shown to be affected 
by different treatments, biological processes, and even different tissues or cell types 
[40, 42, 43]. Therefore, when using a housekeeping gene for normalization, one must 
validate its stability with her/his own samples rather than relying on previously 
published materials [40]. 
Amplification efficiency (E) of the reaction is an important consideration when 
performing relative quantitation. The ideal E value is “1” which means that the PCR 
product concentration doubles during every cycle within the exponential phase of the 
reaction. However, many PCRs do not have ideal E values. Amplification efficiency 
is calculated using data collected from a standard curve with the following formula 
[40]: 
Exponential amplification = 10 (-1/slope)                 (1.1) 
Efficiency = [10 (-1/slope)]-1                                                                                       (1.2) 
There are several methods of relative quantitation. Here the most widely used two 
methods will be described: standard curve method and comparative CT method. 
1.7.2 Standard curve method for relative quantification 
This method uses a standard curve which is generated by using serially diluted 
standards of known concentrations as mentioned also in the description of absolute 
quantification above. Concentrations of target gene and endogenous control gene are 
determined by interpolating from the standard curve for all experimental samples. 
Normalization and then relative expression to calibrator sample for each treated 
sample are then calculated using the concentration values. Because sample quantity 
is divided by calibrator quantity, standard curve units are eliminated, requiring only 
the relative dilution factors of the standards for quantification [40, 42]. 
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This method requires the least amount of validation because the PCR efficiencies of 
the target and endogenous control do not have to be equivalent. It gives highly 
accurate quantitative results [42]. It is also the simplest quantification method [40]. 
However, this method is useful when testing low numbers of targets and small 
numbers of samples and when looking for very discrete expression changes, because 
it requires that each reaction plate contain standard curves, and requires more 
reagents and more space on a reaction plate [42]. 
1.7.3 Comparative CT (CT) method for relative quantification 
This method is similar to the standard curve method, except it is a mathematical 
model and uses arithmetic formulas to obtain the relative quantitation of gene 
expression. The use of this method is only possible when the PCR efficiencies of the 
target and endogenous control are relatively equivalent. Because the comparative C
method does not require a standard curve, it is useful when assaying a large number 
of targets and/or samples since all reaction wells are filled with sample reactions 
rather than standards. Thus, fewer reagents are used [40, 42]. 
In this method, the amount of target, normalized to an endogenous reference and 
relative to a calibrator, is given by the following formula [44]: 
2-Ct                        (1.3) 
1.8 Aim of the Study 
In a previous study with microarray analysis, it was observed that Atf3 and Gadd45g 
genes were upregulated when rat kidney tissues were studied for gene expression 
upon ischemia-reperfusion, ischemia-reperfusion with heat preconditioning and with 
ischemic preconditioning [45, 46]. In this study, the aim was to investigate the 
expression levels of these genes under the same conditions in total RNA samples 
from rat kidney tissues by using quantitative (q) RT-PCR and qReal-Time RT-PCR 
techniques, and to compare the results with the previously obtained microarray 
results. 
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2. MATERIALS AND METHODS 
2.1 Materials and Laboratory Equipment 
2.1.1 Equipments  
The laboratory equipment used in this study is listed in Appendix A. 
2.1.2 Chemicals, Enzymes, Markers, and Buffers 
For agarose gel electrophoresis, agarose from AppliChem was used. 10X TBE was 
prepared with 121.14 g Tris-hydroxymethyl-aminomethan (BDH Laboratory 
Supplies, England), 61.83 g Boric acid (MERCK, Germany), 7.44 g EDTA (Carlo 
Erba Reagents), and adding distilled water to complete the volume to 1 liter. 1X TBE 
was then prepared by 1:10 diluting the 10X TBE. Three µl and 7.5 µl EtBr (10 
mg/ml; Sigma) was used respectively in the mini and midi gels. #SM0323 marker 
(GeneRuler 100bp Plus DNA Ladder) from Fermentas was used. For the DNA 
contamination testing experiments, recombinant Taq DNA Polymerase (#EP0402) 
from Fermentas was used. For making the PCR tubes sterile and free of RNase, 
1:1000 diluted diethyl pyrocarbonate (DEPC; MP Biomedicals) was prepared with 
deionized water. Ethanol (70% v/v; Sigma-Aldrich) was used for common 
sterilization prior to setting of PCR. 
2.1.3 Molecular biological kits 
For RT-PCR, SuperScript III One-Step RT-PCR System with Platinum Taq DNA 
Polymerase kit (for 100 reactions) of Invitrogen was used to synthesize cDNA from 
total RNA in one step. For Real-Time PCR, Transcriptor High Fidelity cDNA 
Synthesis Kit (for 50 reactions) of Roche was used for two-step cDNA synthesis 
prior to PCR, and LightCycler Taqman Master kit (for 96 reactions) of Roche was 
used for PCR on the LightCycler Carousel-Based System using Hydrolysis (Taqman) 
Probes. 
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2.2 RNA Samples 
Total RNAs were used in the experiments. RNAs had been previously isolated from 
kidney tissues of rats (Rattus norvegicus) by using peqGOLD TriFast (peqLab) kit 
[45]. The rats were 30 weeks-old, 220-358 g, male Wistar rats and were exposed to 
ischemia by clamping the left kidneys. A group of the rats had been exposed to “heat 
preconditioning (HP)” and another group to “ischemia preconditioning (IP)” before 
the application of ischemia-reperfusion, whereas the third group of rats had been 
exposed to no preconditioning before. The HP group was exposed to 42 0C for 5 min, 
24 h before ischemia. IP was applied as 3 cycles of ischemia for 5 min and the 
following reperfusion for 10 min. Following the preconditioning, the rats were 
exposed to ischemia for 45 min (I45) and immediately afterwards, to no reperfusion 
(for 0 min, R0), to reperfusion for 15 min (R15), or for 60 min (R60). 
Each RNA sample had two copies (A and B) which were obtained separately from 
two groups of rats. Thus, the RNA samples were composed of three main groups:  
1. Heat Preconditioning (HP) group: The rats in this group were exposed to heat 
preconditioning before ischemia-reperfusion. These samples had sample numbers 
between 1 and 6. 
2. No preconditioning group: The rats in this group were not exposed to any 
preconditioning before ischemia-reperfusion. The sample numbers were between 13 
and 18.  
3. Ischemia Preconditioning (IP) group: The rats in this group were exposed to 
ischemia preconditioning before ischemia-reperfusion. The sample numbers were 
between 25 and 30. 
Additionally, samples called “Sham-A” and “Sham-B” were obtained from rats 
which were exposed only to the same surgical manipulation with other rats, but 
neither to preconditioning nor ischemia-reperfusion. They served as the control 
samples of the study. 
For this thesis work, one copy (A or B) of each RNA sample was chosen. Thus, 
experiments were conducted with the RNA sample numbers 1, 3, 5, 14, 16, 18, 26, 
28, 29 and also Sham-A, Sham-B (Table 2.1). The RNAs were stored at – 80 0C. 
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Table 2.1 : Total RNA samples used in this study [45]. 
N0 
Abbreviations 
of applied 
conditions 
 
Explanation 
Probe1 Probe2 Mixture (µg) 
Concentration 
(µg/µl) 
A 
260/280 
Amount 
(µl) 
1 HP_I45_R0_A Heat preconditioning 
- Ischemia for 45 
min - No reperfusion 
- Copy A 
A 53 a A 78 ca. 30 1.61 2.30 3 
3 HP_I45_R15_A Heat preconditioning 
-Ischemia for 45 min 
- Reperfusion for 15 
min - Copy A 
A 73 b A 74 b ca. 30 1.57 2.32 21 
5 HP_I45_R60_A Heat preconditioning 
-Ischemia for 45 min 
- Reperfusion for 60 
min - Copy A 
A 44 a A 43 ca. 30 1.97 2.27 7 
14 I45_R0_B Ischemia for 45 min 
- No reperfusion - 
Copy B 
A 14 A 18 ca. 30 1.55 1.42 4.5 
16 I45_R15_B Ischemia for 45 min 
- Reperfusion for 15 
min - Copy B 
A 35 A 36 a ca. 30 1.85 1.47 3.5 
18 I45_R60_B Ischemia for 45 min 
- Reperfusion for 60 
min - Copy B 
A 19 A 67 a ca. 30 2.32 1.62 5.5 
26 IP_I45_R0_B Ischemia 
preconditioning - 
Ischemia for 45 min 
- No reperfusion - 
Copy B 
A 65 A 96 30 1.87 1.96 12 
28 IP_I45_R15_B Ischemia 
preconditioning - 
Ischemia for 45 min 
- Reperfusion for 15 
min - Copy B 
A 60 a A 62 a 30 2.52 1.81 7 
29 IP_I45_R60_A Ischemia 
preconditioning - 
Ischemia for 45 min 
- Reperfusion for 60 
min - Copy A 
B 55 B 56 30 1.80 1.64 7.5 
31 Sham_A Control with neither 
preconditioning nor 
ischemia-reperfusion 
- Copy A 
A 39 a A 30 30 2.07 1.96 9 
32 Sham_B Control with neither 
preconditioning nor 
ischemia-reperfusion 
- Copy B 
A 29 a A 42 30 2.25 2.27 10 
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2.3 Multiplex Reverse Transcription-Polymerase Chain Reaction (Multiplex 
RT-PCR) 
RT-PCR was used to amplify the cDNA sequences of the Atf3 and Gadd45g genes, 
and studied as multiplex. For this purpose, a pair of primers (forward, F and reverse, 
R) for the internal control gene Beta-Actin was used as the second primer pair in the 
reaction. 
2.3.1 Primer design  
For the design of primers, coding DNA sequences (CDS) of Atf3, Gadd45g and Actb 
genes of the Rattus norvegicus were used from the UCSC Genome Browser website 
[47] (Appendix B). The primer pairs for the genes were designed by using the 
Primer3Plus website [48] and are listed in the Table 2.2 below. The primers were 
obtained from GenOva (Turkey).  
The primers were confirmed by Amplify 3X software [49] by checking whether they 
actually bind to the related sequences on the genes. The efficiency of binding, the 
amplicon sizes and the primer dimer constructions were also determined by using 
this software. Hairpin structure analysis was performed with the aid of SciTools on 
the IDT website [50]. 
Table 2.2 : Primer pairs used in the RT-PCR study. 
Gene 
Primer       
(F: Forward, 
R: Reverse) 
Primer Sequence Tm (˚C) GC% Product Size  
ATF3 Primer_2_F 5’ CTCCTGGGTCACTGGTGTTT 3’ 60.0 °C 55.0 % 
203 bp 
ATF3 Primer_2_R 5’ CCGCCTCCTTTTTCTCTCAT 3’ 60.7 °C 50.0 % 
GADD45G Primer_1_F 5’ TTGCACGAACTTCTGCTGTC 3’ 60.2 °C 50.0 % 
174 bp 
GADD45G Primer_1_R 5’ CGCCTGGATCAACGTAAAAT 3’ 60.0 °C 45.0 % 
GADD45G Primer_3_F 5’ GGAAAGCATTGCACGAACTT 3’ 60.3 °C 45.0 % 
182 bp 
GADD45G Primer_3_R 5’ CGCCTGGATCAACGTAAAAT 3’ 60.0 °C 45.0 % 
Beta-Actin Primer F 5’ TTGCTGACAGGATGCAGAAG 3’ 60.1 °C 50.0 % 
122 bp 
Beta-Actin Primer R 5’ CAGTGAGGCCAGGATAGAGC 3’ 59.9 °C 60.0 % 
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 2.3.2 Primer dilution
All primers were diluted initially to a final concentration of 100 µM (Table 2.3). 
Subsequently, 1:10 dilutions were made from those stock primer solutions to a final 
concentration of 10 µM. Thus, the primers were ready to be used directly in the RT-
PCR reactions. 
Table 2.3 : Dilution procedure for primer stock solutions. 
Primers Initial dry amount  
(Picomoles) 
Added water (µl) Stock concentration 
(µM) 
Atf3-F 155077 1550.77 100 
Atf3-R 117561 1175.61 100 
Gadd45g-1F 92930 929.30 100 
Gadd45g-1R 82390 823.90 100 
Gadd45g-3F 101505 1015.05 100 
Gadd45g-3R 60952 609.52 100 
Beta-Actin-F 135100.02 1351 100 
Beta-Actin-R 141349.68 1413.5 100 
2.3.3 RNA templates 
All RNA templates shown in Table 2.1 were diluted 1:10 initially. The volume of 
each RNA template to be used in the RT-PCR mixture was then calculated to have 
100 ng of template amount in the reaction mixture (Table 2.4) . When preparing RT-
PCR mixtures, the calculated volumes were taken from the 1:10 diluted stocks. 
Table 2.4 : RT-PCR reaction amounts of the RNA templates. 
RNA 
Template No 
      
1 
      
3 
      
5 
    
14 
    
16 
    
18 
    
26 
    
28 
    
29 
Sham-
A 
Sham-
B 
1:10 diluted 
concentration 
(ng/µl) 
 
161 
 
157 
 
197 
 
155 
 
185 
 
232 
 
187 
 
252 
 
180 
 
207 
 
225 
Reaction 
volume (µl) 
     
0.62 
  
0.63 
  
0.51 
 
0.65 
 
0.54 
  
0.43 
  
0.53 
 
0.40 
 
0.56 
      
0.48 
      
0.45 
Starting 
amount (ng) 
      
100 
   
100 
   
100 
  
100 
  
100 
   
100 
   
100 
  
100 
  
100 
       
100 
       
100 
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2.3.4 RT-PCR mixture 
SuperScript III One-Step RT-PCR System with Platinum Taq DNA Polymerase kit 
(Invitrogen) was used for the preparation of RT-PCR mixture. A standard mixture of 
RT-PCR (except RNA templates and water) with a final volume of 50 µl was 
prepared according to the supplier’s instructions.  
The composition of the standard RT-PCR mixture is shown in Table 2.5. This 
mixture was prepared individually in 200 µl-sterile tubes, not as a mastermix for 
multiple reactions. Sterile and nonpyrogenic distilled water (Eau Bi-Distillée, Galen 
laç Sanayi, Turkey) was used in the reaction mixtures. 
Table 2.5 : Composition of the standard RT-PCR mixture. 
Components Stock Concentration Volume Final Concentration 
2X Reaction Mix 0.4 mM of each dNTP, 
3.2 mM MgSO4 
25 µl 200 µM of each dNTP, 
1.6 mM MgSO4 
Template RNA 155-252 ng/ µl     
(Table 2.4) 
0.40-0.65 µl   
(Table 2.4) 
0.8-1.3 ng/ µl 
Primer Mix (F + R) 
of Target Gene 
10 µM F primer,         
10 µM R primer 
1 µl 0.2 µM F primer,       
0.2 µM R primer 
Primer Mix (F + R) 
of Beta-Actin gene 
10 µM F primer,         
10 µM R primer 
1 µl 0.2 µM F primer,       
0.2 µM R primer 
SuperScript III RT/ 
Platinum Taq Mix 
__ 2 µl __ 
Autoclaved 
distilled water 
__ 20.35-20.60 
µl 
__ 
FINAL VOLUME  50 µl  
The RT-PCR mixture (Table 2.5) was only used during the main (finally optimized) 
multiplex reactions. Beta-Actin primers were not used in the optimization 
experiments. Additionally, in some optimization experiments, half volumes were 
used. A negative control (NC) with no target RNA, in which no amplification should 
be observed, was also used in each experiment.
25 
 
2.3.5 RT-PCR cycle conditions 
Initially used RT-PCR cycle conditions are shown in Table 2.6. Annealing 
temperature and duration, duration of the extension phase, and the cycle repeat 
number of the PCR were further optimized. 
Table 2.6 : General RT-PCR cycle conditions. 
Phase Temperature (˚C) Time Cycle Repeat Number 
cDNA Synthesis 55 30 min 1 
Initial Denaturation 94 2 min 1 
PCR Amplification  
Denaturation 94 15 s 
40 Annealing 53 90 s 
Extension 68 50 s 
Final Extension 68 5 min 1 
2.3.6 Testing of primers and cycle number determination 
The Atf3 and Gadd45g primers were tested by using the RNA sample 3 as target 
whether the primers are binding to their target sequences and amplification is 
observed or not. The RT-PCR program used is shown in Table 2.6. 
For the determination of optimum cycle number (the number after which the band 
brightness is constant, i.e. saturation is observed), two tubes of the same reaction 
mixture (50 µl + 50 µl = 100 µl) were prepared for each gene and 10 µl of the 
reaction mixture was taken from the reaction tubes at the cycle numbers 23, 26, 29, 
32, 35, 38 and 40.  
2.3.7 Testing of genomic DNA contamination of RNA samples 
RNA samples 3, 18 and 26 were tested initially using the both Atf3 and Gadd45g 
primers and in a second experiment, samples 1, 5, 14, 16, 28, 29, Sham-A and Sham-
B were tested using the Gadd45g primers to see whether the samples have any 
genomic DNA contamination or not. Instead of the SuperScript III RT/ Platinum Taq 
Mix, only Taq DNA Polymerase (Fermentas) was used at 0.4 µl volume in the 50 µl 
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total PCR mixture. The initial cDNA synthesis stage was omitted. PCR conditions 
are shown in Table 2.7. 
Table 2.7 : PCR conditions of genomic DNA contamination testing. 
PCR Amplification 
Stages Temperature (
0C) Time Cycle Repeat Number 
Denaturation 94  15 s 
40  Annealing 53  90 s 
Extension 68  50 s 
Final Extension 68  5 min 1 
2.3.8 Testing of primer product/dimer formations 
To test whether the PCR products of the genomic DNA contamination testing 
experiment actually indicate genomic DNAs or primer products/dimers, PCR 
reaction mixtures containing only F or R primer of a primer pair or the primer pair 
itself (F+R) were prepared with the Atf3 and Gadd45g-1 primers. Each forward and 
reverse primer was diluted 1:10 before the reaction, and the previously 1:10 diluted 
forward + reverse primer pairs were used. Thus, all the primer solutions had a 
starting concentration of 10 µM. Any template RNA was not used. Compositions of 
reaction mixtures are indicated in Table 2.8. For the PCR reaction, the PCR program 
indicated in Table 2.7 was used. 
Table 2.8 : Compositions of PCR reaction mixtures prepared to test any primer 
product/dimer formation. 
Components Forward (F) 
primer 
Reverse (R) 
primer 
F + R mixture Negative 
Control 
1. dd H2O 23.6 µl 23.6 µl 23.6 µl 24.6 µl 
2. Rmix 25 µl 25 µl 25 µl 25 µl 
3. Primers 1 µl 1 µl 1 µl - 
4. Taq DNA 
polymerase 
0.4 µl 0.4 µl 0.4 µl 0.4 µl 
Total reaction 
mixture 
50 µl 50 µl 50 µl 50 µl 
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2.3.9 Optimization of PCR amplification for ATF3 
Annealing conditions of 56 0C for 30 seconds and 60 0C for 30 seconds were tested 
for the Atf3 primer pair using the RNA sample number 26. Three tubes of the 
reaction mixture were prepared for each condition: two tubes with the Atf3 primers 
and one tube of negative control. During reactions, 10 µl sample was taken from the 
tubes at the 23., 26., 29., 32., 35., 38. and 40. cycles. 
2.3.10 Optimization of PCR amplification for GADD45G 
Optimization experiments were conducted using two couples of primers (Primer-1F, 
-1R and Primer-3F, -3R) for the Gadd45g gene and the RNA sample number 3 as 
target. Because the first used primer pair (Primer-1) amplified a non-specific region, 
the second primer pair (Primer-3) was then tested. 
2.3.10.1 Gradient-PCR
In Gradient-PCR approach, to determine the optimum annealing temperature, 
different annealing temperatures can be tested at the same time for the same PCR 
reaction mixture in a thermal cycler. For the first primer pair (Primer-1), 11 different 
temperatures (55 0C-65 0C temperature gap) were tested at the same time. For this 
purpose, 11 tubes of the reaction mixture and an NC tube were prepared. The 
reaction mixture was scaled down to a total volume of 25 µl (Table 2.9). Gradient-
PCR program used is shown in Table 2.10. 
Table 2.9 : Reaction mixture for Gradient-PCR with Primer-1. 
Components Sampe-3 (x11) NC (x1) 
dd H2O 10.685 µl 10.685 µl 
Rmix 12.5 µl 12.5 µl 
Primer mix (F+R) 0.5 µl 0.5 µl 
Template 0.315 µl 0.315 µL (dd H2O) 
Enzyme 1 µl 1 µl 
TOTAL 25 µl 25 µl 
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Table 2.10 : Gradient-PCR conditions for the first primer pair of Gadd45g. 
Phase Temperature (˚C) Time Cycle Repeat Number 
cDNA Synthesis 55 30 min 1 
Initial Denaturation 94 2 min 1 
PCR Amplification  
Denaturation 94 15 s 
40 Annealing 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65 30 s 
Extension 68 50 s 
Final Extension 68 5 min 1 
For the second primer pair (Primer-3), 59 0C-64 0C temperature gap was tested in 
Gradient-PCR, and 30 s extension time was used. The full-scale reaction volume (50 
µl total) was used for reaction mixtures. 
2.3.10.2 Touchdown-PCR 
In Touchdown-PCR approach, a high-low temperature gap is used for specific primer 
binding. The highest temperature is above the melting temperature of the primers and 
decreased gradually. Non-specific binding of the primers to non-target sequences of 
DNA is avoided at the higher temperatures [51].  
Thus, firstly, a Touchdown RT-PCR experiment was conducted using the Primer-3 
pair. It had 4 PCR amplification stages: the first two had 3 cycle repeat, the third one 
4 cycle repeat and the last amplification stage had 30 cycle repeat number (totally 40 
cycles). Annealing temperature was decreased by 1 0C at each amplification stage as 
63-62-61 and finally 60 0C. Annealing time was 30 s, whereas the extension time 15 
s. The full-scale reaction volume (50 µl total) was used for reaction mixtures. 
A second Touchdown RT-PCR experiment that had 16 PCR amplification stages was 
set for both of the primer pairs. The first 15 amplification stages were run for 2 
cycles, whereas the last stage was run for 10 cycles. Annealing temperature of the 
first PCR stage was 63 0C (the highest) and decreased by 1 0C at each PCR stage up 
to 48 0C as the lowest temperature. Annealing and extension times were both 30 s. A 
total reaction volume of 25 µl was used as indicated in Table 2.9. 
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The third Touchdown RT-PCR experiment was set for both of the primer pairs. It 
had 6 PCR amplification stages which had 70-68-66-64-62 and finally 61 0C 
annealing temperatures decreasing gradually by 2 0C at each amplification stage. The 
first 5 stages had 3 cycle repeat, whereas the last one (with the 61 0C annealing 
temperature) had 25 cycle repeat number. Annealing time was 30 s, extension time 
was 50 s. The half measurements of the reaction mixture were used, and two tubes 
(25 µl + 25 µl = 50 µl) were prepared with each primer pair. In this case, 5 µl 
reaction mixture was taken from the tubes during the reaction at cycle no: 23, 26, 29, 
32, 35, 38, and 40. 
The last Touchdown RT-PCR experiment was set for both of the primer pairs. It had 
8 PCR amplification stages which had 68-67-66-65-64-63-62 and finally 61 0C 
annealing temperatures decreasing gradually by 1 0C at each amplification stage. The 
first 7 stages had 2 cycle repeat, the last one had 26 cycle repeat number. Annealing 
time was 30 s, extension time was 50 s. Five µ l reaction mixture was taken from the 
tubes during the reaction at cycle numbers: 23, 26, 29, 32, 35, 38, and 40. 
2.3.10.3 Further optimization of annealing and extension times 
During these experiments, only annealing and extension times were changed at 
certain annealing and extension temperatures. Other conditions of RT-PCR program 
were the same as indicated in Table 2.6. 
Annealing times of 30, 20 and 10 s were tested at 61 0C with the Primer-1 pair. At 61 
0C 30 s annealing condition, extension times of 50, 30, 13 and 11 s were tried. The 
reaction mixture that was used in the experiments is shown in Table 2.9. 
With the Primer-3 pair, firstly, extension times of 20, 15 and 10 s were tried at the 60 
0C 30 s annealing condition. Secondly, using the 10 s extension time, the annealing 
time was reduced to 20 s. The full-scale reaction volume (50 µl total) was used for 
reaction mixtures. 
2.3.11 Agarose gel electrophoresis 
Electrophoresis of RT-PCR products was done using 150 ml (2.25 g agarose in 150 
ml 1X TBE) and 60 ml (0.9 g agarose in 60 ml 1X TBE) agarose gels of 1.5 % (w/v). 
TBE buffer (1X) diluted from 10X stock TBE solution was used both in the gels and 
the electrophoresis tank. EtBr was added 7.5 µl to 150 ml gels and 3 µl to 60 ml gels. 
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Ten µl of cDNA samples were loaded into the wells mixing with 5 µl diluted (in 
initial experiments) or with 2 µl undiluted 6X DNA Loading Dye (#R0611, 
Fermentas) in the multiplex experiments, and also 5 and 7 µl with 1 µl of the 
undiluted loading dye in the test experiments. Five µl GeneRuler™ 100bp Plus DNA 
Ladder (#SM0323, Fermentas) (Figure C.1) marker was loaded with multiplex RT-
PCR products, whereas 3 µl and 5 µl of other markers (#SM1103 and #SM1203, 
Fermentas) (Figure C.2 and Figure C.3) were also loaded with the products of 
optimization experiments. 
RT-PCR products were run at 100-120 V for at least 20 min. Bands of the products 
were observed under UV light with the BTX-26.M (Biolab) instrument, and 
photographs were taken using UV PhotoMW software. 
2.3.12 Relative quantification 
Volumes of the RT-PCR product bands were determined from gel images by using 
BioCapt software (Vilber Lourmat). After quantifying the volumes of the Beta-Actin 
bands and the target gene (Atf3, Gadd45g) bands of multiplex RT-PCR experiments, 
log2 values of the volumes were calculated. For each cDNA sample to be 
normalized, the log2 value of the target gene band was divided by the log2 value of 
the Beta-Actin band, and then, average values were calculated for the duplicates. The 
results of the cDNA samples 1, 3, 5, 14, 16, 18, 26, 28, 29 were divided by the 
results of the cDNA samples 31 (Sham-A) and 32 (Sham-B) which are the control 
samples. Thus, the relative expression levels of the Atf3 and Gadd45g genes in the 
treated tissues to those in the non-treated tissues (Sham-A and Sham-B) were 
determined. 
2.4 Multiplex Real-Time PCR 
Multiplex Real-Time PCR was also used to quantify the expression levels of the Atf3 
and Gadd45g genes. cDNA synthesis and real-time PCR kits and LightCycler 2.0 
instrument of Roche were used.  
2.4.1 cDNA synthesis 
cDNA synthesis from the RNA samples was accomplished by using the Transcriptor 
High Fidelity cDNA Synthesis Kit (Roche) according to the supplier’s instructions. 
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cDNA synthesis had two stages: in the first stage, a template-primer mixture (11.4 µl 
totally) was prepared for one 20 µl reaction by adding the components in the order 
listed in Table 2.11.  
Table 2.11 : Template-primer mixture (for one reaction) used in cDNA synthesis  
from RNA samples prior to real-time PCR experiments. 
Component Volume Final concentration 
Water, PCR-grade 8.4 µl _ 
Random Hexamer Primer 
(600 pmol/ µl) 
2 µl 60 µM 
Total RNA 1 µl 1 ng up to 4 µg 
Total volume                                      11.4 µl 
One µl total RNA was used from the undiluted stock solution of the RNA sample to 
be used as standard sample (for standard curve) during real-time PCR experiments. 
For preparing other RNA samples, however, 1 µl total RNA was used from the 1:10 
diluted stock solution. After this step, the template-primer mixture was denatured by 
heating the tube at 65°C for 10 min in a thermal cycler (PCR device) with a heated 
lid (to minimize evaporation). This step ensures denaturation of RNA secondary 
structures. The denaturation was ended by immediately cooling the tube on ice. 
The second stage of cDNA synthesis was the synthesis stage where the remaining 
components of the RT mix were added into the tube containing the template-primer 
mix in the order listed in Table 2.12. The components of the synthesis stage were 
prepared as a mastermix for multiple reactions. 
Table 2.12 : Remaining components of RT mixture (for one reaction). 
Component Volume Final Concentration 
Transcriptor High Fidelity Reverse 
Transcriptase Reaction Buffer,               
5X concentration 
4  µ l 1X                                        
(8 mM MgCl2) 
Deoxynucleotide Mix, 10 mM each 2 µl 1 mM each 
Protector RNase Inhibitor, 40 U/ µl 0.5 µl 20 U 
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Table 2.12 : (Continued) Remaining components of RT mixture (for one reaction). 
Component Volume Final Concentration 
DTT 1 µl 5 mM 
Transcriptor High Fidelity Reverse 
Transcriptase 
1.1 µl 10 U 
Final volume                                                    20 µl 
The tube was then placed in thermal cycler with a heated lid, which was programmed 
according to Table 2.13. Finally, the reaction was stopped by placing the tube on ice. 
The cDNA samples were stored at - 20 0C. 
Table 2.13 : RT-PCR conditions used in cDNA synthesis prior to real-time PCR   
experiments. 
Phase Temperature (˚C) Time Cycle Repeat Number 
Incubation 50 30 min             
1 Inactivation of the 
Reverse Transcriptase 
85 5 min 
2.4.2 Primers and Probes 
Primers and probes used in the real-time PCR experiments (Table 2.14 and 2.15) 
were designed specifically by using mRNA sequences of the genes on the 
ProbeFinder (version 2.44) software on Assay Design Center of the Universal 
ProbeLibrary website of Roche [52]. 
Table 2.14 : Data of the primers used in the real-time PCR experiments. 
Primer Length Position Tm 
(0C) 
% GC Sequence (5’ to 3’) Amplicon 
size (nt) 
ATF3 Left 22 383-404 59 50 tgtcagtcaccaagtctgaggt  
88 ATF3 
Right 
19 452-470 60 47 cacttggcagcagcaattt 
GADD45G 
Left 
19 107-125 59 58 cgtggccaggatacagttc  
75 
GADD45G 
Right 
20 162-181 60 50 cagcagaagttcgtgcaatg 
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Table 2.15 : Data of the probes used in the real-time PCR experiments. 
Probe Gene Catalog number Sequence 
#70 ATF3 04688937001 ggcggcgg 
#76 GADD45G 04688996001 cacagcca 
Before starting the setting up the real-time PCR reaction, the dry lyophilized 
oligomer primers of the Atf3 and Gadd45g genes were diluted. The Beta-Actin 
primer pair was already ready-to-use in the kit and was not diluted further. All probes 
(Atf3, Gadd45g, Beta-Actin) were aliquoted as 10 µl in 200 µl sterile tubes, and the 
tubes were then covered with aluminium foil to prevent reaction with light. 
Primer dilutions were made according to the IDT SciTools Resuspension Calculator 
software on the IDT website [53] by entering the “amount of oligo (OD260)” and 
molecular weight data of the primers, and selecting the “Single-Stranded DNA” 
option. Dilution procedure is shown in Table 2.16. 
Table 2.16 : Dilution procedure for the primers used in real-time PCR experiments. 
Primer Amount of sterile water to be added to 
the primer (µl) 
Stock concentration 
(µM) 
ATF3-F (Left) 733.3 100 
ATF3-R (Right) 860.9 100 
GADD45G-F 685 100 
GADD45G-R 845.6 100 
After preparing the main primer stocks of 100 µM concentration, intermediate stocks 
were also prepared by diluting 20 µl of the main stock at 1:5 (20 µl primer and 80 µl 
sterile water ) to reach the final primer concentration of 20 µM.
2.4.3 Real-Time PCR procedure 
LightCycler TaqMan Master kit of Roche was used for the preparation of real-time 
PCR mixture. It is a ready-to-use hot start reaction mix for PCR on the LightCycler 
carousel-based system (LightCycler 2.0 instrument) using hydrolysis (TaqMan) 
probes [54]. PCR parameters are shown in Table 2.17. 
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Table 2.17 : PCR parameters that must be programmed for a LightCycler carousel-     
based system PCR run with the LightCycler TaqMan Master [54]. 
Analysis Mode Cycles Target Temperature 
(0C) 
Hold Time Acquisition 
Mode 
Pre-Incubation     
None 1 95 10 min None 
Amplification     
Ouantification 45 95 10 s None 
  60 30 s None 
  72 1 s Single 
Cooling     
None 1 40 30 s None 
Pre-incubation is required for activation of FastStart Taq DNA Polymerase and 
denaturation of the DNA. 
Preparation of the PCR mix for a 20 µl standard reaction was done in the order listed 
in Table 2.18. Multiple reactions were set by preparing a mastermix without 
including the target cDNA. 
Table 2.18 : Multiplex real-time PCR mix (for one reaction). 
Component Concentration Volume Final 
Concentration 
Water (PCR-grade) _ 9 µl _ 
Primer Mix                       
(UPL+ Reference Gene Assay) 
20 µM 0.4 µl 400 nM 
Primer (GOI*) forward 
 
20 µM 0.4 µl 400 nM 
Primer (GOI) reverse 
 
20 µM 0.4 µl 400 nM 
Probe                                   
(UPL Reference Gene Assay) 
 
10 µM 0.4 µl 200 nM 
UPL probe (GOI) 
 
10 µM 0.4 µl 200 nM 
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Table 2.18 : (Continued) Multiplex real-time PCR mix (for one reaction). 
Component Concentration Volume Final 
Concentration 
TaqMan Master Mix 5X 4.0 µl 1X 
Total Volume  15 µl                      
Final Volume                     
(with 5 µl cDNA) 
 20 µl   
*GOI: Gene of interest, +UPL: Universal Probe Library 
After preparing the mastermix, 15 µl PCR mix was carefully pipetted into each 
precooled LightCycler capillary tube, and 5 µl of the cDNA template was then 
added. 
In some experiments to obtain standard curve, also singleplex PCR mixtures (without 
Beta-Actin primers and probe) were prepared in the order listed in Table 2.19. 
Table 2.19 : Singleplex real-time PCR mix (for one reaction). 
Component Concentration Volume Final 
Concentration 
Water (PCR-grade) 
 
_ 10.4 µl _ 
Primer (GOI*) forward 
 
20 µM 0.2 µl 200 nM 
Primer (GOI) reverse 
 
20 µM 0.2 µl 200 nM 
UPL+ Probe (GOI) 
 
10 µM 0.2 µl 100 nM 
TaqMan Master Mix 
 
5X 4.0 µl 1X 
Total Volume  15 µl   
Final Volume         
(with 5 µl cDNA) 
 20 µl   
*GOI: Gene of interest, +UPL: Universal Probe Library 
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2.4.4 Standard curve 
For setting of the standard curve, cDNA sample numbers 3 and 32 (Sham-B) were 
used in the reactions in undiluted, 1:10 diluted, 1:100 diluted and 1:1000 diluted 
form. Thus, totally 5 tubes of the reaction mixture were prepared including also a 
negative control tube. The undiluted cDNAs were synthesized from the undiluted 
main RNA stocks. Thereafter, 1:10 diluted cDNA was prepared from the undiluted 
cDNA, the 1:100 diluted was prepared from the 1:10 diluted one and so on. Standard 
curve reactions were set as both multiplex and singleplex to compare the reaction 
efficiencies of the two reactions. 
2.4.5 Multiplex reaction 
Beta-Actin primer pair and probe were used as the second gene components with the 
components of either the target gene Atf3 or Gadd45g in the multiplex reactions. 
Multiplex reactions were set as duplicate, thus with an NC tube, totally 23 tubes of 
the reaction mixture were prepared. 
2.4.6 Relative quantification 
The CT  method [42, 44] was used to calculate the relative gene expressions 
resulting from Real-Time PCR. 
2.5 Statistical Analysis 
The results of RT-PCR, Real-Time PCR and microarray methods which were used 
for quantification of gene expression were analyzed statistically to determine 
whether the three results were significantly different or not. Friedman test was 
applied for this purpose by using SPSS software (version 16.0). The Friedman test is 
a non-parametric test for testing the difference between several related samples. The 
null hypothesis (H0) for the Friedman test is that there are no differences between the 
variables. If the calculated probability is low (P  0.01, or P  0.05) the null-
hypothesis is rejected and it can be concluded that at least 2 of the variables are 
significantly different from each other (Ha) [55, 56]. Kendall’s W [55] value was also 
determined for each condition (IR, HP-IR, and IP-IR). Thus, the Friedman test was 
used for the determination of the difference between the three columns (RT-PCR, 
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Real-Time PCR and microarray results), whereas the Kendall’s W was used for the 
determination of the difference between the three lines (R0, R15 and R60 samples). 
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3. RESULTS
3.1 RT-PCR Primer Tests 
Both Atf3 and Gadd45g primers worked appropriately, i.e. they were able to amplify 
the target sequences. However, the initially used primer pair (Primer-1) of Gadd45g 
also amplified an unwanted non-specific region (~ 300 bp) in addition to the 174 bp 
target sequence (Figure 3.1).  
 
Figure 3.1 : Atf3 and Gadd45g primer products, using the RNA sample-3 as target. 
Explanations of the products indicated on the gel image are given in 
Table 3.1. 
Table 3.1 : Explanations for the agarose gel lanes in Figure 3.1. 
Lane 
number  
Explanation Lane 
number 
Explanation Lane 
number 
Explanation 
1 Marker 
#SM0323 
2 Empty 10 Empty 
  3 Atf3 at cycle number 23 11 Gadd45g at cycle number 23 
  4 Atf3 at cycle number 26 12 Gadd45g at cycle number 26 
  5 Atf3 at cycle number 29 13 Gadd45g at cycle number 29 
  6 Atf3 at cycle number 32 14 Gadd45g at cycle number 32 
  7 Atf3 at cycle number 35 15 Gadd45g at cycle number 35 
  8 Atf3 at cycle number 38 16 Gadd45g at cycle number 38 
  9 Atf3 at cycle number 40 17 Gadd45g at cycle number 40 
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Therefore, a second Gadd45g primer pair (Primer-3) was used. However, this primer 
pair also amplified the non-specific region (~ 300 bp). 
3.2 Testing of Genomic DNA Contamination and Primer Products/Dimers 
All RNA samples used in the study were tested for DNA contamination and it was 
confirmed that they had not been contaminated (Figure 3.2). The observed bands in 
Figure 3.2 indicate only the primer product/dimer formations which were verified 
later (Figure 3.3).  
 
A                                                                  B 
Figure 3.2 : DNA contamination test results of RNA samples no 3, 18, 26 (A), and 
1, 5, 14, 16, 28, 29, Sham-A and Sham-B (B). Explanations for the 
products indicated on the gel image are given in Table 3.2. 
Table 3.2 : Explanations for the agarose gel lanes in Figure 3.2. 
Lane 
number 
Explanation Lane 
number 
Explanation 
1 Marker (#SM0323, Fermentas) a Sample-1 with Gadd45g primers 
2 Sample-3 with Atf3 primers b Sample-5 with Gadd45g primers 
3 Sample-18 with Atf3 primers c Sample-14 with Gadd45g primers 
4 Sample-26 with Atf3 primers d Sample-16 with Gadd45g primers 
5 NC with Atf3 primers e Sample-28 with Gadd45g primers 
6 Sample-3 with Gadd45g primers f Sample-29 with Gadd45g primers 
7 Sample-18 with Gadd45g primers g Sample Sham-A with Gadd45g primers 
8 Sample-26 with Gadd45g primers h -Actin primer control using Sample-3 
9 NC with Gadd45g primers i Sample Sham-B with Gadd45g primers 
 
 j NC with Gadd45g primers 
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Figure 3.3 shows the agarose gel products of the verification experiment of primer 
product/dimer formations. These bands verified the product bands shown in Figure 
3.2 and indicate the primer product/dimer formations, because, the bands (Figure 3.3) 
were only observed for the products of the primer pairs (F + R), and no product band 
was observed for the cases of single primers (F or R). Explanations for the products 
indicated in Figure 3.3 are given in Table 3.3. 
                                                                                            
Figure 3.3 : Agarose gel bands of primer product/dimer formations. 
Table 3.3 : Explanations for the agarose gel lanes in Figure 3.3. 
Lane 
number 
Explanation Lane 
number 
Explanation Lane 
number 
Explanation 
1 Marker 
#SM0323 
2 Atf3 Forward (F) 
primer 
7 Empty 
  3 Atf3 Reverse (R) 
primer 
8 Gadd45g Forward 
primer 
  4 Atf3 F + R primers 9 Gadd45g Reverse 
primer 
  5 Atf3 F + R primers 10 Gadd45g F + R primers 
  6 Atf3 control with no 
primer 
11 Gadd45g control with 
no primer 
3.3 RT-PCR Results of ATF3 
3.3.1 Optimum PCR conditions 
When the RT-PCR products of the optimization experiments for Atf3 were analyzed 
by using the BioCapt software, the annealing condition of 56 0C for 30 s and 32 
cycles of PCR amplification were determined as optimal conditions for the multiplex 
RT-PCR of Atf3 gene. The agarose gel bands of Atf3 at 56 0C were brighter than 
those at 60 0C (Figure 3.4) and image analysis results of 56 0C gave a more accurate 
graph (Table 3.5 and Figure 3.5). 
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Figure 3.4 : RT-PCR products of the annealing optimization experiment at 56 0C 
and 60 0C for the Atf3 primers by using sample-26. Explanations for 
the lane numbers are given in Table 3.4. 
Table 3.4 : Explanations for the agarose gel lanes in Figure 3.4. 
Lane 
number 
Explanation Lane 
number 
Explanation 
1 Marker (#SM0323, Fermentas) 11 Empty 
2 Empty 12 Cycle no 23 at 60 0C 
3 Cycle no 23 at 56 0C 13 Cycle no 26 at 60 0C 
4 Cycle no 26 at 56 0C 14 Cycle no 29 at 60 0C 
5 Cycle no 29 at 56 0C 15 Cycle no 32 at 60 0C 
6 Cycle no 32 at 56 0C 16 Cycle no 35 at 60 0C 
7 Cycle no 35 at 56 0C 17 Cycle no 38 at 60 0C 
8 Cycle no 38 at 56 0C 18 Cycle no 40 at 60 0C 
9 Cycle no 40 at 56 0C 19 NC at cycle no 40 and 60 0C 
10 NC at cycle no 40 and 56 0C 20 Marker (#SM0323, Fermentas) 
Table 3.5 : Image analysis results (volume values) of the Atf3 gene bands shown in 
Figure 3.4. 
Cycle repeat number 23 26 29 32 35 38 40 
                 
Volume 
Threshold=120, 
56 0C 
0 0 345 3363 6356 7338 9372 
Threshold=120, 
60 0C 
0 0 289 14 1130 2170 4122 
As shown in Table 3.5, the band volumes of Atf3 products at cycle number 29, 32, 
35, 38 and 40 showed a more straight increase at 56 0C than those at 60 0C, also as 
shown in Figure 3.5. At the annealing temperature of 56 0C, there was less increase 
of the volume fold after the cycle number 32 with respect to cycles 29 and 32. It 
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seems that the band volume reached the saturation after cycle no 32 and thus, 
optimum cycle was the cycle no 32. 
 
Figure 3.5 : Line graph showing the increase in the band volumes (y axis) given in 
Table 3.5 upon increase in the cycle repeat number (x axis). 
3.3.2 Multiplex RT-PCR of Atf3 
All RNA samples were run in duplicate. Resulting agarose gel (1.5 %, 150 ml) bands 
of cDNAs are shown in Figure 3.6 and explained in Table 3.6. 
 
Figure 3.6 : Multiplex RT-PCR products of Atf3 and -Actin genes. Explanations     
for the 30 lanes indicated on the gel image are given in Table 3.6. 
Table 3.6 : Explanations for the agarose gel lanes in Figure 3.6. 
Lane 
number 
Explanation Lane 
number 
Explanation 
1 Marker #SM0323 
(Fermentas) 
16-17 Sample-28 (IP-I45-R15-B) 
2-3 Sample-1 (HP-I45-R0-A) 18-19 Sample-29 (IP-I45-R60-A) 
4-5 Sample-3 (HP-I45-R15-A) 20-21 Sample Sham-A with Atf3 and          
-Actin primers 
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Table 3.6 : (Continued) Explanations for the agarose gel lanes in Figure 3.6. 
Lane 
number 
Explanation Lane 
number 
Explanation 
6-7 Sample-5 (HP-I45-R60-A) 22-23 Sample Sham-A with only -Actin 
primers 
8-9 Sample-14 (I45-R0-B) 24-25 Sample Sham-B with Atf3 and -Actin 
primers 
10-11 Sample-16 (I45-R15-B) 26-27 Sample Sham-B with only -Actin 
primers 
12-13 Sample-18 (I45-R60-B) 28-29 Controls with only -Actin primers 
using sample-26 
14-15 Sample-26 (IP-I45-R0-B) 30 NC with Atf3 and -Actin primers  
3.3.3 Relative quantification 
Relative quantification of the RT-PCR products of Atf3 gene shown in Figure 3.6 
was done as described in the “Materials and Methods” section of this Thesis (2.3.12. 
Relative quantification). Resulting volume values and calculations are given in 
Appendix D (Table D.1). 
3.4 Multiplex Real-Time PCR Results of ATF3 
Standard curve setting failed for Atf3 with the Sample 3 dilutions; as the undiluted 
cDNA had a CT value higher than 27.00, and the 10-fold diluted cDNA had a CT 
value higher than 40.00. As a result, the efficiency value of Atf3 was higher than 2.5 
and not in the acceptable range (1.8-2.1) [57]. However, error and efficiency values 
of Atf3 were acceptable for the singleplex reaction, and also for the multiplex 
reaction of Beta-Actin gene (Table 3.7). Acceptable value of error is:  0.1 [57]. 
Table 3.7 : Efficiency and error values of Atf3 and -Actin genes using cDNA of 
Sample 3 in real-time PCR experiments. 
 -Actin (in multiplex reaction) ATF3  (in singleplex reaction) 
Efficiency 2.09 2.01 
Error 0.026 0.011 
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In the second set of experiments, Sham-B RNA was chosen as the sample for 
standard curve preparation, because it was one of the highly concentrated samples 
(2.25 µg/µl) with a high volume to produce enough cDNA stock. Again, 10-fold 
dilutions (from undiluted to 1:1000 diluted) were prepared. However, the same 
problem existed in CT values: as the undiluted cDNA had a CT value of 26.00 (a high 
CT), the 10-fold diluted cDNAs had higher CT values than 30.00. As a result, 
efficiency and error values of Sham-B were not acceptable for the multiplex reaction, 
either (Table 3.8). However, Sham-B had acceptable values in singleplex reaction, 
and also Beta-Actin had acceptable values both in multiplex and singleplex reactions 
(Table 3.8). 
Table 3.8 : Efficiency and error values of Atf3 and -Actin genes using Sham-B 
cDNA in real-time PCR experiments. 
 ATF3           
(in multiplex 
reaction) 
ATF3           
(in singleplex 
reaction) 
-Actin        
(in multiplex 
reaction) 
-Actin        
(in singleplex 
reaction) 
Efficiency 1.53 2.07 1.92 1.94 
Error 0.275 0.008 0.017 0.0003 
As the standard curve failed for Atf3 multiplex reaction with both cDNA samples 3 
and Sham-B, CT method was used to calculate the relative Atf3 gene expression in 
each treated sample. The calculations and the resulting fold-changes in gene 
expression are shown in Table 3.9 : if the Atf3 expression in Sham-A was considered 
as basis, i.e. as one-fold, in other words, when the calibrator is Sham-A, Sham-B had 
then two-fold expression of Atf3 relative to Sham-A. Also, when Sham-A was the 
calibrator, the expression in one sample was nearly two-fold of the expression in the 
same sample when the calibrator was Sham-B. The highest increase in Atf3 gene 
expression was observed in the ischemia preconditioning (IP) case, at reperfusion 
time of 60 min. The increase in the Atf3 gene expression of I45_R60_B, 
HP_I45_R60_A and IP_I45_R60_A samples were 19.43, 23.75, and 44.32-fold 
respectively, when Sham-A was used as the calibrator. When Sham-B was used as 
the calibrator, however, these fold-increase values changed as 9.68, 11.84 and 22.09, 
respectively. 
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Table 3.9 : Fold-changes in gene expression of Atf3 after HP-IR, only IR and IP-IR 
treatments, calculated by CT  method. 
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1 HP_I45_R0_A 29.95 20.90 9.06 1.26 0.42 2.26 0.21 
3 HP_I45_R15_A 29.68 21.64 8.04 0.23 0.85 1.24 0.42 
5 HP_I45_R60_A 24.73 21.50 3.24 -4.57 23.75 -3.57 11.84 
14 I45_R0_B 33.08 28.45 4.63 -3.18 9.06 -2.18 4.52 
16 I45_R15_B 30.64 23.42 7.22 -0.59 1.50 0.42 0.75 
18 I45_R60_B 25.60 22.08 3.53 -4.28 19.43 -3.28 9.68 
26 IP_I45_R0_B 26.15 21.47 4.69 -3.12 8.70 -2.12 4.33 
28 IP_I45_R15_B 27.68 22.05 5.63 -2.18 4.53 -1.18 2.26 
29 IP_I45_R60_A 23.32 20.99 2.34 -5.47 44.32 -4.47 22.09 
31 Sham-A 30.03 22.23 7.81 0.00 1.00 1.01 0.50 
32 Sham-B 28.62 21.82 6.80 -1.01 2.00 0.00 1.00 
3.5 Comparison of Relative Gene Expression Results of ATF3 Obtained by RT-
PCR, Real-Time PCR and Previous Microarray Analysis  
RT-PCR and Real-Time PCR results of ATF3 gene expression were compared with 
the previously obtained microarray gene expression data [46] (Table 3.10).  
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Table 3.10 : Comparison of the relative quantification results of ATF3 gene 
expression obtained by RT-PCR, Real-Time PCR and previous 
microarray analysis. 
 Relative Quantification to 
Sham-A 
    Relative Quantification to 
Sham-B 
 
Sample 
number 
                                
Sample name RT-PCR Results 
Real-
Time 
PCR 
Results 
M
ic
ro
ar
ra
y 
R
es
u
lts
 
           
RT-PCR 
Results 
Real-
Time 
PCR 
Results 
M
ic
ro
ar
ra
y 
R
es
u
lts
 
1 HP-I45-R0-A __ 0.42 -1.18 __ 0.21 -1.98 
3 HP-I45-R15-A 0.78 0.85 0.08 0.67 0.42 -0.78 
5 HP-I45-R60-A 1.16 23.75 4.08 1.00 11.84 3.29 
14 I45-R0-B 0.63 9.06 -0.75 0.55 4.52 -1.22 
16 I45-R15-B 1.02 1.50 0.37 0.88 0.75 -0.50 
18 I45-R60-B 1.27 19.43 3.96 1.10 9.68 3.24 
26 IP-I45-R0-B 1.18 8.70 3.07 1.02 4.33 2.31 
28 IP-I45-R15-B 0.96 4.53 2.40 0.83 2.26 1.63 
29 IP-I45-R60-A 1.24 44.32 4.54 1.07 22.09 3.65 
31 Sham-A 1.00 1.00 __ 0.86 0.50 __ 
32 Sham-B 1.16 2.00 __ 1.00 1.00 __ 
3.6 RT-PCR Results of GADD45G 
3.6.1 Primer-1 and Primer-3 results 
In the Gadd45g optimization experiments, because the first used primer pair (Primer-
1) gave an undesirable non-specific product (Figure 3.7 B), the second primer pair 
(Primer-3) was tried. However, the second primer pair also resulted in the same non-
specific product (Figure 3.7 A). 
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A                                           B 
Figure 3.7 : Agarose gel bands of products of first (B) and second (A) Gadd45g 
primer pairs. The full-scale reaction volume (50 µl of total) was used 
for reaction mixtures of both primer pairs. RNA Samples 3 and 26 
were used respectively for the second and first primers. For both 
primer pairs, annealing condition was 56 0C for 30 s, and the other 
conditions of the RT-PCR experiments were the same as shown in 
Table 2.6.  
Explanations for the gel lanes indicated in Figure 3.7 are given in Table 3.11. 
Table 3.11 : Explanations for the agarose gel lanes in Figure 3.7. 
Volumes of the agarose gel bands shown in Figure 3.7 are given in Table 3.12. 
Threshold volume was 146 for the bands of the products of both primers. 
 
 
Lane 
number 
Explanation Lane 
number 
Explanation 
1 Marker #SM0323 (Fermentas) 9 NC with Primer-3 
2 Cycle no 23 with Primer-3 a Cycle no 23 with Primer-1 
3 Cycle no 26 with Primer-3 b Cycle no 26 with Primer-1 
4 Cycle no 29 with Primer-3 c Cycle no 29 with Primer-1 
5 Cycle no 32 with Primer-3 d Cycle no 32 with Primer-1 
6 Cycle no 35 with Primer-3 e Cycle no 35 with Primer-1 
7 Cycle no 38 with Primer-3 f Cycle no 38 with Primer-1 
8 Cycle no 40 with Primer-3 g Cycle no 40 with Primer-1 
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Table 3.12 : Volumes of Primer-1 and Primer-3 products shown in Figure 3.7. 
3.6.2 Gradient-PCR results 
None of the annealing temperatures tested in Gradient-PCR experiments for both the 
primer pairs were successful to prevent the amplification of the non-specific product 
(Figure 3.8). 
       
A                                                                           B 
Figure 3.8 : Agarose gel images of the products of Gradient-PCR experiments by 
using Primer-1 (A) and Primer-3 (B) primers of Gadd45g and RNA 
Sample 3 as template. Explanations for the lanes indicated on the gel 
image are given in Table 3.13. 
Table 3.13 : Explanations for the agarose gel lanes in Figure 3.8. 
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23 - - - - - - 
26 - 131 - - 18 - 
29 - 669 - 0 3268 - 
32 389 4700 12,08 33 16645 504,39 
35 1229 7488 6,09 1679 25490 15,18 
38 1432 7651 5,34 3309 28424 8,59 
40 4397 13657 3,11 4576 30011 6,56 
Lane 
number 
Explanation Lane 
number 
Explanation 
55-65 55-65 0C Annealing temperatures for 
Primer-1 
4 Annealing at 61 0C for Primer-3 
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Table 3.13 : (Continued) Explanations for the agarose gel lanes in Figure 3.8. 
Volumes of the agarose gel bands shown in Figure 3.8 are given in Table 3.14. 
Threshold volume was 120 for the Primer-1 products, and 200 for the Primer-3 
products. 
Table 3.14 : Volumes of Primer-1 and Primer-3 products shown in Figure 3.8. 
 Primer-1 products Primer-3 products 
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55 2250 9080 4.04 - - - 
56 2996 10727 3.58 - - - 
57 2667 10488 3.93 - - - 
58 2139 9237 4.32 - - - 
59 3027 10878 3.59 174 9891 56.84 
60 2426 10071 4.15 6278 24636 3.92 
61 2277 10171 4.47 1992 20643 10.36 
62 580 5392 9.30 0 4617 - 
63 448 4911 10.96 0 0 - 
64 0 1485 - 0 0 - 
65 0 0 - - - - 
Lane 
number 
Explanation Lane 
number 
Explanation 
M Marker #SM1203 (Fermentas)  5 Annealing at 62 0C for Primer-3 
1 Marker #SM0323 (Fermentas) 6 Annealing at 63 0C for Primer-3 
2 Annealing at 59 0C for Primer-3 7 Annealing at 64 0C for Primer-3 
3 Annealing at 60 0C for Primer-3 8 NC, Annealing at 60 0C for Primer-3 
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3.6.3 Optimum PCR conditions 
Any of the optimization experiments could not eliminate the non-specific band (~ 
300 bp). Increasing the annealing temperature and decreasing the annealing and 
extension times, decreased the volume and brightness of the agarose gel band for 
both the non-specific product and Gadd45g. However, the first primer pair was 
determined to bind to the target sequence more efficiently compared with the second 
primer (Figure 3.7 and 3.8, and Table 3.12 and 3.14), as the first primer was already 
specified as the best primer by the Primer3Plus program. The first primer pair could 
amplify the target sequence at 56 0C and higher temperatures (Figure 3.8 A). 
However, these results were obtained using only the RNA Sample 3 as template, and 
amplification may not be observed at higher temperatures than 56 0C when using 
other samples as template. At the 56 0C of annealing temperature, brightness and 
volume of agarose gel band of Sample 3 product by using Primer-1 reached the 
saturation at the cycle number 35 (Figure 3.7 B and Table 3.12). Thus, beginning 
from cycle number 35, the band brightness and volume became constant in 
comparison to the cycle numbers before 35, and cycle number 32 seemed as the 
optimum cycle repeat number for Sample 3. As a result of these and the other 
optimization experiments, the annealing condition of 56 0C for 30 s, extension time 
of 50 s, and 32 cycles of PCR amplification were determined as optimum conditions 
for multiplex RT-PCR of Gadd45g using Primer-1. 
3.6.4 Multiplex RT-PCR of Gadd45g 
All RNA samples were run in duplicate. Resulting agarose gel (1.5 %, 150 ml) bands 
are shown in Figure 3.9 and explained in Table 3.15. 
 
Figure 3.9 : Multiplex RT-PCR products of Gadd45g and -Actin genes. 
Explanations for the lanes indicated on the gel image are given in 
Table 3.15. 
 
52 
 
Table 3.15 : Explanations for the agarose gel lanes in Figure 3.9. 
Lane 
number 
Explanation Lane 
number 
Explanation 
M Marker #SM0323 15-16 Sample-28 (IP-I45-R15-B) 
1-2 Sample-1 (HP-I45-R0-A) 17-18 Sample-29 (IP-I45-R60-A) 
3-4 Sample-3 (HP-I45-R15-A) 19-20 Sample Sham-A with Gadd45g and 
-Actin primers 
5-6 Sample-5 (HP-I45-R60-A) 21-22 Sample Sham-A with only -Actin 
primers 
7-8 Sample-14 (I45-R0-B) 23-24 Sample Sham-B with Gadd45g and 
-Actin primers 
9-10 Sample-16 (I45-R15-B) 25-26 Sample Sham-B with only -Actin 
primers 
11-12 Sample-18 (I45-R60-B) 27-28 Controls with only -Actin primers 
using sample-26 
13-14 Sample-26 (IP-I45-R0-B) N NC with Gadd45g and -Actin 
primers  
3.6.5 Relative quantification 
Relative quantification of the RT-PCR products of Gadd45g gene observed in Figure 
3.9 was done as described in the “Materials and Methods” section of this Thesis 
(2.3.12. Relative quantification). Resulting volume values and calculations are shown 
in Appendix D (Table D.2). Because no band volume was detected in Sham samples, 
resulting value for each sample could not be divided by a Sham value. Therefore, 
Sham values were considered as 1-fold, and the normalized value for each sample 
was considered as the fold-change expression to Sham samples. 
3.7 Multiplex Real-Time PCR Results of GADD45G 
A standard curve was obtained successfully for Gadd45g gene using the 10-fold 
dilutions of cDNA Sample 3. The efficiency and error values of multiplex reaction 
are shown in Table 3.16, which were both in acceptable ranges. Thus, Sham-B was 
not used as a new sample for a second set of experiments to obtain a new standard 
curve. 
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Table 3.16 : Efficiency and error values of Gadd45g and -Actin genes using  
Sample 3 cDNA in real-time PCR experiments. 
 Gadd45g (in multiplex reaction) -Actin  (in multiplex reaction) 
Efficiency 2.14 1.94 
Error 0.002 0.026 
However, it is generally recommended to set the standard curves of both Atf3 and 
Gadd45g genes using the same standard sample. As the cDNA Sample 3 did not 
work as a standard with Atf3, and thus the relative Atf3 gene expression was 
calculated using the CT method, the relative gene expression of Gadd45g was also 
calculated using the same method. The calculations and the resulting fold-changes in 
Gadd45g gene expression are shown in Table 3.17. 
Table 3.17 : Fold-changes in gene expression of Gadd45g after HP-IR, only IR and 
IP-IR treatments, calculated by CT  method. 
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1 HP_I45_R0_A 27.58 21.03 6.55 1.22 0.43 1.53 0.35 
3 HP_I45_R15_A 27.57 21.84 5.73 0.40 0.76 0.71 0.61 
5 HP_I45_R60_A 26.34 22.11 4.23 -1.11 2.15 -0.80 1.74 
14 I45_R0_B 34.48 29.25 5.23 -0.11 1.08 0.20 0.87 
16 I45_R15_B 28.63 23.58 5.05 -0.29 1.22 0.03 0.98 
18 I45_R60_B 26.85 22.69 4.16 -1.18 2.26 -0.87 1.82 
26 IP_I45_R0_B 26.22 21.94 4.28 -1.06 2.08 -0.75 1.68 
28 IP_I45_R15_B 27.12 22.53 4.59 -0.75 1.68 -0.44 1.35 
29 IP_I45_R60_A 25.60 21.59 4.01 -1.33 2.50 -1.02 2.02 
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Table 3.17 : (Continued) Fold-changes in gene expression of Gadd45g after HP-IR, 
only IR and IP-IR treatments, calculated by CT  method. 
Sa
m
pl
e 
N
u
m
be
r 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sa
m
pl
e 
N
a
m
e 
G
a
dd
45
g 
A
v
er
a
ge
 
C
T 

-
A
ct
in
 
A
v
er
a
ge
 
C
T 

C
T 
=
 
C
T 
G
A
D
D
45
G
 
–
 
C
T 
BE
TA
-
A
CT
IN
 
 


C
T 
=
 

C
T 
tr
ea
te
d 
–
 

C
T 
Sh
am
-
A
 
 
Fo
ld
 
di
ffe
re
n
ce
 
in
 
G
a
dd
45
g 
re
la
tiv
e 
to
 
Sh
a
m
-
A
 
(2-


Ct
) 


C
T 
=
 

C
T 
tr
ea
te
d 
–
 

C
T 
Sh
am
-
B
 
 
Fo
ld
 
di
ffe
re
n
ce
 
in
 
G
a
dd
45
g 
re
la
tiv
e 
to
 
Sh
a
m
-
B 
(2-


Ct
) 
31 Sham-A 27.62 22.28 5.34 0.00 1.00 0.31 0.81 
32 Sham-B 26.81 21.78 5.03 -0.31 1.24 0.00 1.00 
As in Atf3 gene expression, the highest increase in Gadd45g gene expression was 
observed in the ischemia preconditioning (IP) case with 60 min of reperfusion time. 
Generally, expression levels in HP-treated samples were lower than those in the only 
ischemia-reperfusion-treated samples (Table 3.17), whereas expression in IP-treated 
samples was higher than in the only ischemia-reperfusion-treated samples (Table 
3.17). 
3.8 Comparison of Relative Gene Expression Results of GADD45G Obtained by 
RT-PCR, Real-Time PCR and Previous Microarray Analysis 
RT-PCR and Real-Time PCR results of GADD45G gene expression were compared 
with the previously obtained microarray gene expression data [46] (Table 3.18).  
Table 3.18 : Comparison of the relative quantification results of GADD45G gene 
expression obtained by RT-PCR, Real-Time PCR and previous 
microarray analysis. 
 Relative Quantification to 
Sham-A 
Relative Quantification to 
Sham-B 
 
Sample 
number 
                       
Sample name 
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Results 
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Results M
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RT-PCR 
Results 
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R
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u
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1 HP-I45-R0-A __ 0.43 -0.57 __ 0.35 -0.43 
3 HP-I45-R15-A 0.66 0.76 0.41 0.66 0.61 0.60 
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Table 3.18 : (Continued) Comparison of the relative quantification results of 
GADD45G gene expression obtained by RT-PCR, Real-Time PCR 
and previous microarray analysis. 
 Relative Quantification to 
Sham-A 
Relative Quantification to 
Sham-B 
     
Sample 
number 
 
Sample name 
           
RT-PCR 
Results 
Real-
Time 
PCR 
Results M
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a
rr
a
y 
R
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u
lts
 
            
RT-PCR 
Results 
Real-
Time 
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Results M
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a
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a
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R
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u
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5 HP-I45-R60-A 0.61 2.15 1.02 0.61 1.74 1.28 
14 I45-R0-B __ 1.08 -0.01 __ 0.87 0.31 
16 I45-R15-B 0.76 1.22 -0.09 0.76 0.98 0.17 
18 I45-R60-B 0.75 2.26 0.88 0.75 1.82 1.13 
26 IP-I45-R0-B 0.42 2.08 1.01 0.42 1.68 1.22 
28 IP-I45-R15-B 0.38 1.68 0.94 0.38 1.35 1.19 
29 IP-I45-R60-A __ 2.50 1.52 __ 2.02 1.69 
31 Sham-A __ 1.00 __ __ 0.81 __ 
32 Sham-B __ 1.24 __ __ 1.00 __ 
3.9 Results of Statistical Analysis 
The Friedman non-parametric test was applied to both the Atf3 and Gadd45g results 
of RT-PCR, Real-Time PCR and previous microarray analysis. For both genes, the 
relative gene expressions with respect to Sham-A and Sham-B were determined to be 
significantly different ( 0.01) or not (> 0.01) between the three results. The 
statistical analysis was conducted separately for each case (HP, IR, IP). Thus, for 
each case, the number of subjects was three (N = 3, for R0, R15 and R60) and the 
number of conditions was also three (k = 3, for RT-PCR, Real-Time PCR and 
microarray analysis). Zero “0” was used as the relative expression value for the 
samples with no expression value (-). In addition to the Friedman test that was used 
to determine the difference between the conditions (k), Kendall’s W value was also 
56 
 
used to determine the difference between the subjects (N). Kendall's W ranges from 
0 (complete difference) to 1 (no difference) [55]. 
For the expression of Gadd45g gene, the level of significance was 0.097 (W = 0.778) 
for the HP samples calibrated to Sham-A; 0.264 (W = 0.444) for the HP samples 
calibrated to Sham-B; 0.097 (W = 0.778) for both the IR samples calibrated to Sham-
A and Sham-B, and 0.05 (W = 1.00) for both the IP samples calibrated to Sham-A 
and Sham-B. As all of these values were higher than the significance level of 0.01, 
there was not a significant difference between the results of the three methods for all 
the three (HP, IR, IP) conditions of Gadd45g.  
For the expression of Atf3 gene, the level of significance was 0.097 (W = 0.778) for 
HP samples calibrated to Sham-A; 0.264 (W = 0.444) for the HP samples calibrated 
to Sham-B; 0.097 (W = 0.778) for the IR samples calibrated to Sham-A; 0.264 (W = 
0.444) for the IR samples calibrated to Sham-B, and 0.05 (W = 1.00) for both the IP 
samples calibrated to Sham-A and Sham-B. As all of these values were higher than 
the significance level of 0.01, there was not a significant difference between the 
results of the three methods for all the three (HP, IR, IP) conditions of Atf3. 
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4. DISCUSSION AND CONCLUSIONS 
In this study, expression levels of Atf3 and Gadd45g genes under ischemia followed 
by reperfusion (IR), HP before ischemia-reperfusion and IP before ischemia-
reperfusion conditions were investigated in total RNA samples from rat kidney 
tissues by using RT-PCR and qReal-Time RT-PCR techniques. Both techniques were 
successfully applied with necessary optimizations and it was observed that there 
were significant differences in the expression levels of the above-mentioned genes 
under different conditions. The results obtained were compared with the previously 
obtained DNA microarray results and were found to be compatible with the 
microarray data. 
The overall comparison of the relative gene expression levels for Atf3 and Gadd45g 
indicated that, although there were differences in the absolute values, relative 
quantification based on the controls Sham-A or Sham-B generally yielded similar 
results (Table 3.10 and Table 3.18). 
For Atf3 gene expression, it can be concluded that under HP and IP conditions prior 
to ischemia-reperfusion, the Atf3 gene expression increases when the reperfusion 
time increases. The highest and most significant level of Atf3 expression under HP 
and IP conditions was observed at 60 min reperfusion time (Table 3.10). For these 
conditions, the RT-PCR, Real-Time PCR and microarray results were all parallel. In 
the case of IR samples, there is also a general positive effect of prolonged 
reperfusion time on Atf3 gene expression, the 60 min reperfusion time sample having 
the highest relative gene expression level in this group (Table 3.10). 
In the case of Gadd45g gene expression, Real-Time PCR and microarray results were 
also generally compatible. Also for Gadd45g, it was generally observed that the gene 
expression level increased with increasing reperfusion time, with the highest 
Gadd45g expression observed with 60 min reperfusion time samples of each 
treatment group. In IP group, there was a slight decrease in Gadd45g expression at 
the reperfusion time of 15 min, as compared to zero reperfusion time sample. This 
result was obtained both by Real-Time PCR and microarray data (Table 3.18). 
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Interestingly, similar observation was also made for the IP group samples of Atf3 
gene expression (Table 3.10). It seems like a typical early response of IP-tissues 
upon IR treatment. RT-PCR results of Gadd45g were generally compatible with 
Real-Time PCR and microarray results at the 0- and 15 min-reperfusion times of the 
all three cases (HP, IR and IP), however, there was a decrease in the gene expression 
at the reperfusion time of 60 min in all the cases for RT-PCR results (Table 3.18). 
This can be explained by the great differences in the band volumes of duplicate 
samples (Table D.2). Because all experimental steps and calculations are done 
manually in RT-PCR method, this study shows one more time the low sensitivity of 
the RT-PCR method (Table D.1 and Table D.2) compared to Real-Time PCR method 
(Table D.3). 
Interestingly, for both Atf3 and Gadd45g genes, the highest expression levels were 
observed in the IP group, at 60 min of reperfusion time. This is seemingly an 
important result implying the significant genetic effect of the beneficial IP treatment. 
For the 60 min reperfusion time and the IP samples, relative gene expression values 
of Atf3 were higher than the values of Gadd45g. For both genes, the highest values 
were observed with the Real-Time PCR results which again implies the high 
sensitivity of the technique. In addition to these findings, the long-term effects of 
reperfusion should also be studied with a similar experimental setup, to investigate 
the effects of reperfusion times longer than 60 min. 
A previous study by Yin et al. (1997) [58] supports the result obtained in this study. 
In the study, Atf3 expression levels in rat kidney were examined by Northern 
analysis. No detectable levels of Atf3 mRNA was observed in control kidneys or 
kidneys subjected to ischemia for 1 h. However, within 20 min following 
reperfusion, Atf3 mRNA level increased significantly, reached maximal level by 1.5 
h, was maintained at a high level for at least 3 h, and returned to the basal level by 24 
h. It was concluded that ischemia followed by reperfusion leads to a rapid and 
transient expression of this stress-responsive gene in the kidney as a consequence of 
stress kinase activation. 
In a similar study, Atf3 expression was shown to be increased also in both ischemic 
and ischemic-reperfused rat hearts by using in situ hybridization using antisense 
RNA probes [59]. Ischemia was applied for two hours and reperfusion for one hour. 
Atf3 expression in ischemic-reperfused hearts was higher than in ischemic hearts, 
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and Atf3 was expressed in a larger area in myocardium in the ischemia-reperfusion 
case. In that study, it was also shown and hypothesized that in non-stressed liver, 
gadd153/Chop10 (gadd stands for growth arrest and DNA-damaging; Chop stands 
for C/EBP-homologous protein) inhibits the limited amount of Atf3 by forming an 
inactive heterodimer with it, whereas in carbon tetrachloride (CCl4)-injured liver, the 
synthesis of gadd153/Chop10 was repressed, allowing the induced Atf3 to function. 
A recent in vivo study examined whether Atf3 plays a role in IRI [60]. At first, the 
changes in Atf3 levels were characterized in the kidney of a mouse model of IRI. In 
the kidney, at 12 and 24 h after ischemia there was a significant increase in Atf3 
mRNA levels and corresponding increases in Atf3 protein levels. Immunofluorescent 
staining of kidney showed that, with IRI, Atf3 protein was localized principally in 
the nuclei of the distal tubules. Secondly, protective effect of overexpression of Atf3 
was examined by using adenovirus gene transfer in the model of IRI in the mouse 
kidney. Overexpression of Atf3 mRNA and protein in the kidney was confirmed by 
RT-PCR and Western blot analysis. It was observed that the injury observed in the 
kidneys of mice injected with AdAtf3 (the adenovirus vector encoding the human 
ATF3 gene) was attenuated compared with control mice. An improvement in renal 
function and in the acute tubular necrosis (ATN) score was also observed in the 
kidneys of IRI mice with Atf3 overexpression compared with control mice. As a 
result of the study, Atf3 was found to protect the kidney from IRI. 
In an ischemic preconditioning study on rat spinal cord, it was observed that Atf3 
was robustly induced (8-fold by qRT-PCR and 2-fold by microarray analysis) at 30 
min of reperfusion after 6 min of ischemia and remained elevated until returning to 
baseline by 24 h, whereas it was not induced upon 3 min of ischemia [61]. 
In another study of cardiac ischemic preconditioning on rats by using microarray 
analysis, IP (two repeats of 5 min-ischemia and 10 min-reperfusion) down-regulated 
the expression of several transcripts including Atf3 which were up-regulated by IR 
(40 min-ischemia and 30 min-reperfusion) [62]. 
A recent study of brain ischemia-reperfusion model on rats by using microarray 
analysis showed 12.5-fold increase in Atf3 gene expression after 6 h-reperfusion; and 
8.5-fold increase after 6 h-reperfusion and 15.4-fold increase after 24 h-reperfusion 
in Gadd45g gene expression following 15 min of ischemia [63]. 
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A recent study also examined gene expression profiles in response to myocardial 
infarction after 24 h of ischemia by using microarray analysis in murine model. In 
Atf3 and Gadd45g gene expression, 15-fold and 12-fold increase was observed 
respectively, compared with Sham controls [64]. 
In parallel with the findings mentioned above, fold-change increases in Atf3 and 
Gadd45g gene expression were observed in this study as reperfusion time was 
increased under different conditions (HP, IR, IP) with constant ischemia duration (45 
min) (Table 3.10 and Table 3.18). The down-regulation of Atf3 was observed in the 
cardiac IP study [62], however, the response of Atf3 gene expression may be variable 
in different organs as in the cases of kidney [58] and heart [59] mentioned above. 
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APPENDIX A 
 
 
Balances    Precisa 125A SCS 
Precisa XB 620C 
Centrifuges    Eppendorf Centrifuge 5424 
Electrophoresis Equipment  E - C MINI CELL PRIMO EC320 
E - C MIDI CELL PRIMO EC330 
BIO-RAD PowerPac Basic 
Gel Documentation System  Biolab BTX-26.M 
UVI PhotoMW Version 99.05 for Windows 
Pipettes    Eppendorf 2.5 l, 10 l, 100 l, 200 l, 1000 l 
RT-PCR    Techne TC-412 
Techne TC-312 
Gradient PCR   Corbett PalmCycler 
Real-Time PCR   Roche LightCycler 2.0 
Vortex    Heidolph REAX top 
Magnetic Stirrer   Labword-online 
Deep Freezers & Refrigerators - 80 0C Sanyo 
- 20 0C, + 4 0C Arçelik 
PCR tubes    Deltalab 0.2 ml PCR tubes 
     Axygen 0.5 ml PCR tubes 
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APPENDIX B  
 
ATF3 (NM_012912, Strand -) :  
ATGATGCTTCAACATCCAGGCCAGGTCTCTGCCTCAGAAGTCAGCGCGACCGCC
ATCGTCCCCTGCCTCTCACCTCCTGGGTCACTGGTGTTTGAGGATTTTGCTAACCT
GACACCTTTTGTCAAGGAAGAGCTGAGATTCGCCATCCAGAACAAGCACCTTTG
CCATCGGATGTCCTCTGCGCTGGAGTCAGTCACCATCAACAACAGACCTCTGGA
GATGTCAGTCACCAAGTCTGAGGTGGCCCCTGAAGAAGATGAGAGAAAAAGGA
GGCGGCGGGAAAGAAACAAAATTGCTGCTGCCAAGTGTCGAAACAAGAAAAAA
GAGAAGACAGAGTGCCTGCAGAAGGAGTCAGAGAAACTGGAGAGTGTGAATGC
CGAACTGAAGGCCCAGATCGAGGAGCTGAAGAATGAGAAGCAGCATCTGATTT
ACATGCTCAACCTGCACCGGCCCACGTGTATCGTCCGGGCTCAGAACGGGCGGA
CGCCGGAAGACGAGAGGAACCTTTTTATCCAACAGATAAAAGAAGGAACATTG
CAGAGCTAA 
 
GADD45G (AB020978, Strand -) :  
ATGACTCTGGAAGAAGTCCGTGGCCAGGATACAGTTCCGGAAAGCACAGCCAG
GATGCAGGGCGCCGGGAAAGCATTGCACGAACTTCTGCTGTCGGCGCAGCGCCA
GGGCTGTCTGACCGCTGGCGTCTACGAGTCCGCCAAAGTCCTGAATGTGGACCC
TGACAATGTGACCTTTTGCGTGCTGGCTGCCGACGAAGAAGATGAGGGCGACAT
AGCCCTGCAGATCCATTTTACGTTGATCCAGGCGTTCTGCTGCGAGAACGACATT
GACATCGTGCGCGTGGGAGACGTGCAGAGGCTGGCGGCGATCGTGGGCGCCGA
CGACGAGGGGGGCGCGCCGGGAGACTTGCATTGCATCCTCATTTCGAACCCTAA
TGAAGACACATGGAAGGACCCTGCCTTGGAGAAGCTCAGTTTGTTCTGCGAGGA
GAGCCGCAGCTTCAACGACTGGGTGCCCAGCATCACCCTTCCCGAGTGA 
 
ETA-ACTIN (NM_031144, Strand +) :  
ATGGATGACGATATCGCTGCGCTCGTCGTCGACAACGGCTCCGGCATGTGCAAG
GCCGGCTTCGCGGGCGACGATGCTCCCCGGGCCGTCTTCCCCTCCATCGTGGGCC
GCCCTAGGCACCAGGGTGTGATGGTGGGTATGGGTCAGAAGGACTCCTACGTGG
GCGACGAGGCCCAGAGCAAGAGAGGCATCCTGACCCTGAAGTACCCCATTGAA
CACGGCATTGTCACCAACTGGGACGATATGGAGAAGATTTGGCACCACACTTTC
TACAATGAGCTGCGTGTGGCCCCTGAGGAGCACCCTGTGCTGCTCACCGAGGCC
CCTCTGAACCCTAAGGCCAACCGTGAAAAGATGACCCAGATCATGTTTGAGACC
TTCAACACCCCAGCCATGTACGTAGCCATCCAGGCTGTGTTGTCCCTGTATGCCT
CTGGTCGTACCACTGGCATTGTGATGGACTCCGGAGACGGGGTCACCCACACTG
TGCCCATCTATGAGGGTTACGCGCTCCCTCATGCCATCCTGCGTCTGGACCTGGC
TGGCCGGGACCTGACAGACTACCTCATGAAGATCCTGACCGAGCGTGGCTACAG
CTTCACCACCACAGCTGAGAGGGAAATCGTGCGTGACATTAAAGAGAAGCTGTG
CTATGTTGCCCTAGACTTCGAGCAAGAGATGGCCACTGCCGCATCCTCTTCCTCC
CTGGAGAAGAGCTATGAGCTGCCTGACGGTCAGGTCATCACTATCGGCAATGAG
CGGTTCCGATGCCCCGAGGCTCTCTTCCAGCCTTCCTTCCTGGGTATGGAATCCT
GTGGCATCCATGAAACTACATTCAATTCCATCATGAAGTGTGACGTTGACATCCG
TAAAGACCTCTATGCCAACACAGTGCTGTCTGGTGGCACCACCATGTACCCAGG
CATTGCTGACAGGATGCAGAAGGAGATTACTGCCCTGGCTCCTAGCACCATGAA
GATCAAGATCATTGCTCCTCCTGAGCGCAAGTACTCTGTGTGGATTGGTGGCTCT
ATCCTGGCCTCACTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTAC
GATGAGTCCGGCCCCTCCATCGTGCACCGCAAATGCTTCTAG
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APPENDIX C  
 
 
 
Figure C.1 : GeneRuler™ 100bp Plus DNA Ladder, ready-to-use (#SM0323, 
Fermentas) 
  
Figure C.2 : O'GeneRuler™ DNA Ladder, Low Range, ready-to-use (#SM1203, 
Fermentas) 
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Figure C.3 : FastRuler™ DNA Ladder, Low Range, ready-to-use (#SM1103, 
Fermentas) 
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APPENDIX D 
 
Table D.1 : Calculations of multiplex RT-PCR quantification of Atf3 gene 
expression for duplicate samples (Threshold = 120). 
Sample 
Name 
Band 
volume 
of Atf3 
Band 
volume of 
-Actin 
Log2 value 
of Atf3 
volume 
Log2 value 
of  -Actin 
volume 
Normalized 
value 
Average of 
duplicate 
values 
1_1 0 4679 __ 12.1919845 __  
1_2 0 7140 __ 12.8017084 __     --- 
3_1 37 11363 5.2094534 13.4720562 0.38668584  
3_2 928 12779 9.857981 13.6414873 0.72264708 0.554666 
5_1 1916 11865 10.903882 13.5344245 0.80564060  
5_2 2773 11949 11.437232 13.5446023 0.84441253 0.825027 
       
14_1 32 9183 5 13.1647498 0.37980213  
14_2 115 9286 6.8454901 13.1808416 0.51935152 0.449577 
16_1 1165 16197 10.186114 13.983439 0.72844128  
16_2 1052 15025 10.038919 13.8750774 0.72352166 0.725981 
18_1 5275 14249 12.364955 13.7985731 0.89610392  
18_2 5214 11990 12.348175 13.5495440 0.91133509 0.90372 
       
26_1 3185 13831 11.637078 13.7556179 0.84598728  
26_2 3067 14459 11.582613 13.8196802 0.83812450 0.842056 
28_1 681 12024 9.4115110 13.5536293 0.69439047  
28_2 609 12923 9.2502984 13.6576534 0.67729779 0.685844 
29_1 3762 11241 11.877284 13.4564828 0.88264403  
29_2 3640 10017 11.829723 13.2901629 0.89011119 0.886378 
       
ShamA2_1 232 9973 7.857981 13.2838118 0.59154564  
ShamA2_2 2235 10500 11.126059 13.3581017 0.83290720 0.712226 
 
ShamA1_1 11965  13.5465328   
ShamA1_2 10220  13.3191076   
       
ShamB2_1 1572 8654 10.618386 13.0791514 0.81185584  
ShamB2_2 1991 8634 10.959278 13.0758134 0.83813352 0.824995 
 
ShamB1_1 7543  12.8809227   
ShamB1_2 8173  12.9966500   
       
-Actin_1  6867  12.7454643   
-Actin_2  5584  12.4470832   
ShamA2 and ShamB2 samples contain both Atf3 and -Actin primers whereas ShamA1 and ShamB1 
samples are control samples and contain only the -Actin primers. -Actin duplicate are also control 
samples and contain only -Actin primers. 
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Table D.2 : Calculations of multiplex RT-PCR quantification of Gadd45g gene 
expression for duplicate samples (Threshold = 122). 
Sample 
Name 
Band 
volume of 
Gadd45g 
Band 
volume of 
-Actin 
Log2 value 
of Gadd45g 
volume 
Log2 value 
of -Actin 
volume 
Normalized 
value 
Average of 
duplicate 
values 
1_1 0 12108 __ 13.563673 __  
1_2 0 17478 __ 14.093253 __ __ 
3_1 819 17804 9.6777196 14.119914 0.68539509  
3_2 490 17112 8.9366379 14.062721 0.63548428 0.6604397 
5_1 101 16904 6.6582115 14.045077 0.47406016  
5_2 1775 19686 10.793603 14.264882 0.75665561 0.6153579 
       
14_1 0 0 __ __ __  
14_2 5 21161 2.3219281 14.369120 0.16159153 __ 
16_1 3149 24281 11.620678 14.567540 0.79771038  
16_2 1078 17930 10.074142 14.130088 0.71295675 0.7553336 
18_1 2741 21871 11.420487 14.416732 0.79216892  
18_2 1031 19053 10.009829 14.217731 0.70403842 0.7481037 
       
26_1 634 22325 9.3083390 14.446373 0.64433746  
26_2 7 16904 2.8073549 14.045077 0.19988177 0.4221096 
28_1 39 17801 5.2854022 14.119671 0.37432900  
28_2 43 19310 5.4262648 14.237061 0.38113659 0.3777328 
29_1 0 12631 __ 13.624681 __  
29_2 4 18444 2 14.170864 0.14113466 __ 
       
ShamA2_1 0 12000 __ 13.550747 __  
ShamA2_2 0 12780 __ 13.641600 __ __ 
ShamA1_1 12187     
ShamA1_2 12916     
       
ShamB2_1 0 9722 __ 13.247037 __  
ShamB2_2 0 7260 __ 12.825754 __ __ 
ShamB1_1 10463     
ShamB1_2 10022     
       
-Actin_1  7970     
-Actin_2  4984     
ShamA2 and ShamB2 samples contain both Gadd45g and -Actin primers whereas ShamA1 and 
ShamB1 samples are control samples and contain only the -Actin primers. -Actin duplicate are also 
control samples and contain only -Actin primers. 
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Table D.3 : CT values of duplicate samples from multiplex real-time PCR 
experiments for Atf3 and Gadd45g genes.                                                                                  
Sample 
name 
ATF3      
CT values 
GADD45G 
CT values 
1_1 29.97 27.48 
1_2 29.93 27.67 
3_1 29.65 27.56 
3_2 29.70 27.57 
5_1 24.75 26.33 
5_2 24.71 26.34 
14_1 32.86 33.99 
14_2 33.29 34.96 
16_1 30.82 28.59 
16_2 30.46 28.66 
18_1 25.64 26.83 
18_2 25.56 26.86 
26_1 26.20 26.13 
26_2 26.10 26.30 
28_1 27.74 27.22 
28_2 27.61 27.01 
29_1 23.33 25.56 
29_2 23.31 25.63 
ShamA_1 30.04 27.68 
ShamA_2 30.02 27.55 
ShamB_1 28.53 26.95 
ShamB_2 28.70 26.66 
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